General symptoms and signs

R18_GENERAL_SYMPTOMS_SIGNS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R50-R69 Cause of death: ICD-10 — R50-R69 2 out of 7 registries used, show all original rules.	147133
4. Check minimum number of events None	147133
5. Include endpoints R18_FEVER_OTHER_UNKNO_ORIGIN R18_HEADACHE1 R18_PAIN_NOT_ELSEW_CLASSIFIED R18_MALAI_FATIG R18_SENILITY R18_SYNCO_COLLAP R18_CONVU_NOT_ELSEW_CLASSIFIED R18_SHOCK_NOT_ELSEW_CLASSIFIED R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED R18_ENLARGED_LYMPH_NODES R18_OEDEMA_NOT_ELSEW_CLASSIFIED R18_HYPERHIDROSIS R18_LACK_EXPEC_NORMAL_PHYSIO_DEVELOPMENT R18_SYMPTOMS_SIGNS_CONCERNI_FOOD_FLUID_INTAKE R18_CACHEXIA R18_OTHER_GENERAL_SYMPTOMS_SIGNS R18_UNKNO_UNSPE_CAUSES_MORBIDI	149376
6. Filter based on genotype QC (FinnGen only)	143840

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R
Name in latin: Symptomata et signa generalia

NAME	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	R18_FEVER_OTHER_UNKNO_ORIGIN\|R18_HEADACHE1\|R18_PAIN_NOT_ELSEW_CLASSIFIED\|R18_MALAI_FATIG\|R18_SENILITY\|R18_SYNCO_COLLAP\|R18_CONVU_NOT_ELSEW_CLASSIFIED\|R18_SHOCK_NOT_ELSEW_CLASSIFIED\|R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED\|R18_ENLARGED_LYMPH_NODES\|R18_OEDEMA_NOT_ELSEW_CLASSIFIED\|R18_HYPERHIDROSIS\|R18_LACK_EXPEC_NORMAL_PHYSIO_DEVELOPMENT\|R18_SYMPTOMS_SIGNS_CONCERNI_FOOD_FLUID_INTAKE\|R18_CACHEXIA\|R18_OTHER_GENERAL_SYMPTOMS_SIGNS\|R18_UNKNO_UNSPE_CAUSES_MORBIDI
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R[5-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R[5-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to General symptoms and signs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	143840	82295	61545
Unadjusted period prevalence (%)	28.77	29.19	28.20
Median age at first event (years)	56.41	51.94	62.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
73979: Matched controls
370570

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1310

SPAT

Counselling related to known health issue

1.4

323.3

19218

72969

C07AB02

ATC

metoprolol; systemic

1.6

321.6

10291

34334

N06AX26

ATC

vortioxetine; oral

2.0

321.5

4626

12231

E86

ICD-10 Finland

Volume depletion

3.8

321.2

1258

1669

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

321.2

13536

48029

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

320.5

3179

7262

N06AX12

ATC

bupropion; oral

1.9

319.4

4669

12413

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

318.7

3585

8633

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.8

318.7

586

337

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

317.2

5507

15510

P29

ICPC

Psychological sympt/compl other

1.9

315.7

4581

12145

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

315.1

3925

9838

J01FA10

ATC

azithromycin; systemic

1.4

313.9

37965

162021

R33

ICD-10 Finland

Retention of urine

2.0

313.7

3940

9907

J02AC01

ATC

fluconazole; systemic

1.4

313.1

23835

94417

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

312.3

3909

9815

SPAT1234

SPAT

Support of social functional capacity

2.4

309.1

2587

5467

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

9.0

308.7

560

315

R03DC03

ATC

montelukast; oral

1.6

308.2

9770

32491

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

308.1

7229

22257

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

307.7

5547

15804

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

307.7

7546

20295

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

307.7

1896

2944

N03AX12

ATC

[U] gabapentin; oral

2.6

307.7

11539

24920

B01AB05

ATC

enoxaparin; parenteral

1.7

307.7

18786

62279

C03CA01

ATC

furosemide; systemic

2.2

307.7

17825

47588

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

14992

43894

ZX120

NOMESCO Finland

Intravenous

2.3

307.7

5801

13003

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

307.7

4662

8873

N02BF02

ATC

pregabalin; oral

2.7

307.7

3736

7130

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.2

307.7

1655

1172

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

307.7

5711

12707

ZXE00

NOMESCO Finland

One hour or less

1.5

307.7

24374

90193

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

307.7

7694

15073

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

307.7

1939

3120

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

307.7

3191

7161

N05AX08

ATC

risperidone; systemic

2.3

307.7

4975

11468

A06AD11

ATC

lactulose; oral

2.2

307.7

8702

21106

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

307.7

5756

14074

SPAT1240

SPAT

Therapeutic discussion

1.8

307.7

7127

20318

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

26302

90899

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

307.7

33647

136939

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.5

307.7

4126

4799

R13

ICD-10 Finland

Dysphagia

2.2

307.7

3673

8609

Z3231

NOMESCO Finland

Registered nurse

1.8

307.7

17538

55764

J01DA01

ATC

[U] cefalexin

1.5

307.7

40617

168892

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

4795

9976

XF404

NOMESCO Finland

Ambulatory ECG

2.3

307.7

4947

11400

N05AX12

ATC

aripiprazole; systemic

2.5

307.7

2735

5634

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

307.7

21832

81814

S97

ICPC

Chronic ulcer skin

2.4

307.7

3054

6635

B01AA03

ATC

warfarin; systemic

1.7

307.7

9623

29418

R50.9

ICD-10 Finland

Fever, unspecified

13.3

307.7

18680

9175

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.5

307.7

2394

3546

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

307.7

3735

7605

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

307.7

4486

11064

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

307.7

3262

6432

UKC02

NOMESCO Finland

Cystoscopy

1.8

307.7

8560

25228

L28

ICPC

Limited function/disability (L)

2.2

307.7

10251

25627

G47.3

ICD-10 Finland

Sleep apnoea

1.6

307.7

13454

45531

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

307.7

11753

31532

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.8

307.7

4338

8107

J01MA12

ATC

levofloxacin; systemic

2.1

307.7

11721

30378

H02AB07

ATC

prednisone; oral

1.7

307.7

7648

23387

R51.81

ICD-10 Finland

Facial pain NOS

9.8

307.7

1992

1048

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

307.7

3668

7784

SPAT1260

SPAT

Consultation of another employee

1.6

307.7

10391

33646

A02BC01

ATC

omeprazole; systemic

1.7

307.7

16971

55077

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

19796

68611

X58

ICD-10 Finland

Exposure to other specified factors

1.7

307.7

8937

27535

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

11194

33418

P01

ICPC

Feeling anxious/nervous/tense

1.7

307.7

8265

25421

G44.2

ICD-10 Finland

Tension-type headache

2.6

307.7

10236

21924

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

307.7

4985

12694

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

307.7

8025

18703

N30.0

ICD-10 Finland

Acute cystitis

1.8

307.7

9647

28653

Z2221

NOMESCO Finland

Medical doctor

1.5

307.7

16355

59494

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

307.7

14946

38712

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

307.7

10198

32550

Z3226

NOMESCO Finland

Physiotherapist

1.8

307.7

10920

32681

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

307.7

6183

14792

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

24910

84675

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

307.7

3295

7231

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

9.4

307.7

862

465

L01

ICPC

Neck symptom/complaint

1.7

307.7

9262

29521

L03

ICPC

Low back symptom/complaint

1.6

307.7

17207

59644

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

307.7

7164

16304

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

307.7

5896

16163

A46

ICD-10 Finland

Erysipelas

2.0

307.7

8443

22662

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

307.7

5353

11727

C07AB07

ATC

bisoprolol; oral

1.8

307.7

29657

100298

J01FA06

ATC

roxithromycin; oral

1.5

307.7

24302

92761

R52.0

ICD-10 Finland

Acute pain

5.9

307.7

2721

2388

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

29.8

307.7

1841

317

N03AG01

ATC

valproic acid; systemic, rectal

3.7

307.7

4667

6573

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.3

307.7

1359

1092

ZXD05

NOMESCO Finland

Urgent procedure

1.7

307.7

20053

65708

R11

ICD-10 Finland

Nausea and vomiting

2.8

307.7

6105

11430

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

307.7

2857

6166

R05

ICPC

Cough

1.5

307.7

14276

50815

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

13.0

307.7

3083

1240

R53

ICD-10 Finland

Malaise and fatigue

4.5

307.7

22708

33329

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

21908

76597

SPAT1229

SPAT

Assessment of need for aid

2.4

307.7

4052

8898

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

307.7

4457

10412

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

307.7

3681

8211

N06AX11

ATC

mirtazapine; oral

2.0

307.7

24037

72082

J01MA14

ATC

moxifloxacin; systemic

2.1

307.7

5115

12768

H02AB06

ATC

prednisolone; systemic

1.9

307.7

32736

109649

S18

ICPC

Laceration/cut

1.6

307.7

28355

103911

S06.0

ICD-10 Finland

Concussion

2.3

307.7

7389

17029

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

28490

99799

SPAT1301

SPAT

No procedures

1.6

307.7

19556

67813

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

307.7

7030

18899

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

9380

25499

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

307.7

10705

21134

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

37286

143546

R06AE07

ATC

cetirizine; oral

1.4

307.7

28602

112458

N06AB10

ATC

escitalopram; oral

1.8

307.7

14374

43854

N05BA12

ATC

alprazolam; oral

1.8

307.7

5639

15847

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

307.7

2209

3736

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

35523

138467

R02

ICPC

Shortness of breath/dyspnoea

2.0

307.7

7734

20806

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

19725

60888

P01AB01

ATC

metronidazole; oral, rectal

1.6

307.7

25727

93283

N03AX09

ATC

lamotrigine; oral

3.5

307.7

3846

5749

J01AA02

ATC

doxycycline; systemic

1.5

307.7

51216

219593

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

307.7

36279

148945

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

307.7

5838

16593

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

28159

102506

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

307.7

2822

5959

XA800

NOMESCO Finland

Neuropsychological investigation

2.7

307.7

2653

5126

AA1AD

NOMESCO Finland

CT of head and brain

3.4

307.7

21132

39029

SPAT1255

SPAT

Intravenous administration of medicine

2.2

307.7

3810

8774

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

307.7

10266

34157

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

307.7

4694

8975

Z2445

NOMESCO Finland

Psychologist

2.5

307.7

2568

5223

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

307.7

1722

2739

N03AE01

ATC

clonazepam; systemic

3.0

307.7

3739

6457

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

307.7

5969

14305

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

8746

20124

R52.9

ICD-10 Finland

Pain, unspecified

3.3

307.7

7635

12323

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

307.7

7536

15449

WZC30

NOMESCO Finland

Teaching

1.8

307.7

9092

26933

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

307.7

2900

5875

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

16968

56190

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

18498

50935

R51

ICD-10 Finland

Headache

3.9

307.7

4641

6298

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

16192

48541

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

34276

136020

WX892

NOMESCO Finland

Monitored bed care

2.4

307.7

4492

9646

J01EA01

ATC

trimethoprim; systemic

1.5

307.7

15034

53467

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

7409

21426

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

307.7

3950

9552

N05CD07

ATC

temazepam; oral

1.9

307.7

6191

17420

K30

ICD-10 Finland

Functional dyspepsia

1.8

307.7

6541

18933

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

307.7

33235

90598

TAB00

NOMESCO Finland

Lumbar puncture

3.6

307.7

3197

4652

N05CF01

ATC

zopiclone; oral

1.8

307.7

20673

64829

N05BA04

ATC

oxazepam; oral

2.0

307.7

18024

51225

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

307.7

4957

13293

N06AX16

ATC

venlafaxine; oral

2.3

307.7

10483

24969

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

307.7

6933

17861

C03DA01

ATC

spironolactone; oral

1.8

307.7

6124

17336

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

63482

269273

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

307.7

6135

10072

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

307.7

7978

22189

M54.2

ICD-10 Finland

Cervicalgia

2.0

307.7

4624

12037

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

307.7

6647

16667

J01DB01

ATC

cefalexin; oral

1.9

307.7

59129

249178

B01AC04

ATC

clopidogrel; oral

1.7

307.7

7747

23881

M04AA01

ATC

allopurinol; systemic

1.8

307.7

6446

18719

ZY010

NOMESCO Finland

Hospital outpatient

2.3

307.7

3333

7400

N06AB06

ATC

sertraline; oral

2.0

307.7

7543

20200

L03AA02

ATC

filgrastim; parenteral

3.3

307.7

1613

2500

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

307.7

8072

23687

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

15520

38261

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

29985

93734

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

20062

52050

A29

ICPC

General symptom/complaint other

1.8

307.7

7002

20087

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

307.7

15814

53856

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

307.7

3632

7706

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

20221

71194

N03AF01

ATC

carbamazepine; oral, rectal

3.0

307.7

3120

5280

N06AB03

ATC

fluoxetine; oral

1.8

307.7

7366

21267

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

8489

22803

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

307.7

10162

23070

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

307.7

9962

27525

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

307.7

11788

34521

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

307.7

24754

95187

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

47879

172407

SPAT1216

SPAT

Assessment of functional ability

1.8

307.7

8107

23211

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.3

307.7

2947

4644

R55

ICD-10 Finland

Syncope and collapse

28.8

307.7

12743

2656

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

29568

105444

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

307.7

8619

25582

M79.7

ICD-10 Finland

Fibromyalgia

3.0

307.7

2141

3667

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

307.7

22898

84783

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

307.7

7324

19245

M03BX02

ATC

tizanidine; oral

1.5

307.7

41224

168455

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

125.0

307.7

1227

C08CA01

ATC

amlodipine; oral

1.5

307.7

20389

75188

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

307.7

7805

11912

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

307.7

16568

52281

P03

ICPC

Feeling depressed

1.8

307.7

6608

19331

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

14683

47188

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

307.7

4895

10637

JN4AD

NOMESCO Finland

Body CT examination

2.4

307.7

5875

12874

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

307.7

5057

12203

M01AB05

ATC

diclofenac; systemic, rectal

1.4

307.7

42172

182488

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

28270

94509

JN4BD

NOMESCO Finland

Extensive body CT

2.4

307.7

6092

13296

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

+∞

307.7

827

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

307.7

6389

18609

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

8363

16186

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

307.7

6150

10918

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

307.7

11638

38974

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

37501

153633

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

307.7

13843

38517

J01FF01

ATC

clindamycin; systemic

1.7

307.7

17488

56559

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

12269

37672

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

307.7

9487

24549

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

307.7

2733

5088

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

307.7

13264

35543

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

307.7

11507

33871

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

307.7

11368

36395

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

17442

59688

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

307.7

15038

49795

H02AB02

ATC

dexamethasone; systemic

2.0

307.7

6237

16577

R52.2

ICD-10 Finland

Other chronic pain

8.0

307.7

3144

2050

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

307.7

7433

21694

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

6020

14412

N17

ICPC

Vertigo/dizziness

1.9

307.7

6709

18712

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

307.7

3750

8420

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

23856

84043

Z2446

NOMESCO Finland

Social worker

2.6

307.7

4307

8760

N05CF02

ATC

zolpidem; oral

1.7

307.7

10465

33472

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

307.7

14579

39241

R56.8

ICD-10 Finland

Other and unspecified convulsions

253.0

307.7

6666

145

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

307.7

4741

12273

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

307.7

3756

8529

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

30993

122913

N02BF01

ATC

gabapentin; oral

2.4

307.7

5028

11147

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

307.7

1372

1928

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

307.7

5679

14725

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.9

307.7

2465

4310

H02AB04

ATC

methylprednisolone; systemic

1.7

307.7

8237

25464

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

307.7

12194

39495

N06AB04

ATC

citalopram; systemic

1.9

307.7

13731

39580

A04

ICPC

Weakness/tiredness general

2.1

307.7

9670

25152

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

307.7

6410

11695

79199

ICD-8 Finland

Headache

+∞

307.7

1048

R4110

NOMESCO Finland

Physiotherapy

1.7

307.7

16859

54960

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

17595

48142

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

307.7

4804

12345

C07AA05

ATC

propranolol; systemic

1.8

307.7

13400

41301

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

307.7

9749

20214

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

307.7

2471

4964

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

307.7

49007

213646

J01CA04

ATC

amoxicillin; systemic

1.5

307.7

56844

254585

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

307.7

3331

6505

A02BC03

ATC

lansoprazole; oral

1.6

307.7

16964

57412

M79.1

ICD-10 Finland

Myalgia

1.8

307.7

9087

26360

N03AX16

ATC

[U] pregabalin

2.5

307.7

16744

39066

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

307.7

2398

3795

E0000UV, ,

ATC

1.4

307.7

26239

103188

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

307.7

25212

100293

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

307.7

10441

24119

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

307.7

16199

59524

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

307.7

4284

10015

R07.3

ICD-10 Finland

Other chest pain

2.1

307.7

6057

15017

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.4

307.7

2443

3682

R60.0

ICD-10 Finland

Localized oedema

4.7

307.7

9802

11770

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.6

307.7

1166

1063

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.2

307.7

1617

1148

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

307.7

5765

13258

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

307.7

9881

32518

N03AF02

ATC

oxcarbazepine; oral

5.7

307.7

2624

2396

Z51.5

ICD-10 Finland

Palliative care

2.4

307.7

3868

8437

UJF32

NOMESCO Finland

Coloscopy

1.9

307.7

16135

47697

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

307.7

18888

69247

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.4

307.7

3067

6549

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

307.7

6019

14442

A04AA01

ATC

ondansetron; systemic, rectal

2.4

307.7

4818

10450

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

9701

23226

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

307.7

12069

34320

G43.9

ICD-10 Finland

Migraine, unspecified

3.0

307.7

4589

8093

ZXA00

NOMESCO Finland

Right side

1.5

307.7

14387

50840

SPAT1254

SPAT

Administration of medicine

2.0

307.7

9420

25000

N05AH04

ATC

quetiapine; oral

2.3

307.7

13499

32401

N03AX14

ATC

levetiracetam; systemic

6.1

307.7

2151

1806

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

49169

206795

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

307.7

9454

25473

K02.1

ICD-10 Finland

Caries of dentine

1.4

307.7

39466

167750

N02AA05

ATC

oxycodone; systemic

2.6

307.7

11119

23470

A03

ICPC

Fever

1.7

307.7

11462

36092

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

307.7

2095

3432

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

307.7

3225

5142

WX002

NOMESCO Finland

Sedation and analgesia

1.7

307.7

10754

34167

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.7

307.7

925

540

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

307.7

16341

42944

WW500

NOMESCO Finland

Blood transfusion

2.9

307.7

2248

4024

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

12.9

307.7

771

303

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.9

307.7

758

483

N06AA09

ATC

amitriptyline; systemic

2.5

307.7

5797

12395

A01

ICPC

Pain general/multiple sites

2.4

307.7

5671

12518

W19

ICD-10 Finland

Unspecified fall

1.9

307.7

5697

15581

R51.80

ICD-10 Finland

Headache

13.1

307.7

20855

10769

A02BA02

ATC

ranitidine; systemic

1.7

307.7

10612

33466

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

307.7

3619

7144

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.4

307.7

1530

2303

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

307.7

1805

2887

I95.1

ICD-10 Finland

Orthostatic hypotension

3.6

307.7

1847

2585

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

27601

81103

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

307.7

19302

61727

R60.9

ICD-10 Finland

Oedema, unspecified

4.6

307.7

3930

4483

R52.1

ICD-10 Finland

Chronic intractable pain

33.6

307.7

771

116

Z71.8

ICD-10 Finland

Other specified counselling

1.6

307.7

20053

71047

SPAT1153

SPAT

Removal of sutures

1.5

307.7

17621

65211

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

307.7

3617

8463

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

307.7

2490

4427

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

307.7

10478

29560

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

307.7

6009

11154

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

307.7

2007

3125

N06AX21

ATC

duloxetine; oral

2.7

307.7

8704

17238

A28

ICPC

Limited function/disability NOS

2.2

307.7

9172

22095

M54.5

ICD-10 Finland

Low back pain

1.7

307.7

24344

81150

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.4

307.7

2659

2143

N05AA02

ATC

levomepromazine; systemic

2.8

307.7

2479

4477

N05AH03

ATC

olanzapine; systemic

2.6

307.7

4382

8761

R63.4

ICD-10 Finland

Abnormal weight loss

5.1

307.7

2538

2564

N01

ICPC

Headache

2.2

307.7

8137

20102

N03AX11

ATC

topiramate; oral

4.0

307.7

1756

2257

SPAT1263

SPAT

Sampling

1.6

307.7

27646

101344

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

306.5

2963

6690

H02AB09

ATC

hydrocortisone; systemic

3.4

305.8

1415

2123

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

8.6

305.2

568

333

183

Kela drug reimbursment

Lamotrigin and topiramate

7.0

305.0

657

476

ZXA05

NOMESCO Finland

Left side

1.5

304.5

13230

47173

WX402

NOMESCO Finland

General anaesthesia

1.5

303.9

12457

43875

N07BB01

ATC

disulfiram; oral

2.4

303.6

2675

5791

A08

ICPC

Swelling

2.4

303.6

2531

5338

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

303.4

3398

8165

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

302.8

3096

7162

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

302.4

2047

3881

XF402

NOMESCO Finland

ECG with work load test

1.8

301.4

5310

15015

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

300.6

3852

9755

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

299.3

11907

41655

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

298.6

6809

20788

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

297.9

3456

8421

127

Kela drug reimbursment

Transplant complication

4.3

297.4

996

1160

A11

ICPC

Chest pain NOS

2.0

297.2

4246

11188

G43.3

ICD-10 Finland

Complicated migraine

3.9

296.7

1130

1466

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

14.6

296.7

422

146

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

296.1

3514

8639

A10AB05

ATC

insulin aspart; parenteral

1.9

294.2

4259

11273

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

294.1

1474

2334

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

293.6

3029

7032

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

292.5

3704

9336

SPAT1262

SPAT

Handing over of treatment supplies

1.6

291.7

9287

30881

WX290

NOMESCO Finland

Other blockage of nerve

1.3

291.6

30937

128800

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

291.1

2287

4684

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

289.7

10487

35911

D11

ICPC

Diarrhoea

1.7

287.1

7252

22750

R00.2

ICD-10 Finland

Palpitations

1.9

287.0

4478

12160

SFA10

NOMESCO Finland

One-surface restoration

1.3

286.6

35657

151913

Z00.0

ICD-10 Finland

General medical examination

1.5

284.5

11271

39348

P76

ICPC

Depressive disorder

1.9

284.0

4179

11121

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

283.8

2112

4208

R05

ICD-10 Finland

Cough

1.5

282.5

12087

42876

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.7

281.8

1948

3734

EBA00

NOMESCO Finland

Extraction of tooth

1.4

281.6

22297

88509

R56.0

ICD-10 Finland

Febrile convulsions

619.0

281.0

369

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

280.7

2200

4500

M48.0

ICD-10 Finland

Spinal stenosis

1.7

280.6

5868

17463

A04AA02

ATC

granisetron; systemic, transdermal

2.1

280.0

3255

7933

L04AA06

ATC

mycophenolic acid; systemic

3.6

280.0

1164

1616

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

279.8

2587

5722

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

279.8

9011

30020

R03BB04

ATC

tiotropium bromide; inhalant

1.8

279.4

5071

14461

C01DA14

ATC

isosorbide mononitrate; oral

1.7

279.2

7035

22046

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

278.7

2564

5659

E87.6

ICD-10 Finland

Hypokalaemia

2.8

278.5

1719

3094

M01AH05

ATC

etoricoxib; oral

1.3

278.1

38626

166934

R4120

NOMESCO Finland

Occupational therapy

2.0

277.8

3598

9141

R61.0

ICD-10 Finland

Localized hyperhidrosis

14.9

277.6

391

132

N03AX18

ATC

lacosamide; systemic

7.9

277.6

547

350

R41.0

ICD-10 Finland

Disorientation, unspecified

3.1

277.3

1489

2464

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

277.3

7765

25000

R01AD09

ATC

mometasone; nasal

1.3

276.6

28556

118071

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

276.3

2246

4677

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

275.8

1760

3228

D06

ICPC

Abdominal pain localized other

1.8

275.4

5050

14444

L12

ICPC

Hand/finger symptom/complaint

1.6

275.2

9369

31606

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

275.2

4980

14185

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

273.1

5499

16179

H03AA01

ATC

levothyroxine sodium; systemic

1.5

272.9

12815

46284

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

272.8

3454

8699

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

271.3

1847

3511

C09AA05

ATC

ramipril; oral

1.5

271.1

12367

44400

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

269.8

1301

2007

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

268.7

4089

11002

P06

ICPC

Sleep disturbance

1.6

268.5

7037

22265

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

268.5

2876

6778

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

268.2

23848

96238

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

267.8

4980

14301

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

267.2

15220

56987

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

263.6

4203

11486

B34.9

ICD-10 Finland

Viral infection, unspecified

2.6

262.5

1837

3543

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.4

261.9

1203

1795

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

260.5

6781

21407

SPAT1312

SPAT

General health counselling

1.4

260.4

19381

75937

P15

ICPC

Chronic alcohol abuse

2.7

259.1

1769

3367

C09CA06

ATC

candesartan; oral

1.4

258.3

13082

47880

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

258.2

2862

6839

S29

ICPC

Skin symptom/complaint other

1.5

257.6

10595

37199

K59.0

ICD-10 Finland

Constipation

2.1

257.4

2963

7189

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

256.2

3059

7529

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

255.8

3845

10297

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

255.7

1631

2990

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.3

255.5

869

1026

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

255.4

13842

51295

J01FA09

ATC

clarithromycin; systemic

1.4

255.2

18612

72632

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

255.2

11146

39612

D07AC01

ATC

betamethasone; topical

1.4

254.4

21143

84251

SPAT1097

SPAT

Recording of ECG

1.6

253.8

7271

23510

R4190

NOMESCO Finland

Nutritional therapy

2.4

253.4

2179

4659

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

253.1

1173

1761

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.6

252.8

1072

1510

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

251.2

6681

21198

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

251.1

4208

11684

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

250.2

16634

63874

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.2

249.7

523

365

R74

ICPC

Upper respiratory infection acute

1.4

249.6

20558

81748

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

249.1

6769

21593

AN1

Coronary angiography

1.8

248.4

4955

14521

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

248.3

5145

15247

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

248.0

6437

20291

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

247.6

2672

6314

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.4

247.4

1152

1735

M01AH01

ATC

celecoxib; oral

1.5

246.8

9434

32585

S01.0

ICD-10 Finland

Open wound of scalp

1.9

246.5

4129

11462

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

246.0

2936

7223

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

245.5

11979

43476

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.1

244.8

868

1062

TK800

NOMESCO Finland

Hemodialysis

3.3

244.5

1157

1762

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.5

243.2

1857

3746

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

243.1

4327

12245

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

242.4

1217

1928

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

242.4

2076

4429

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

242.1

3647

9769

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

241.7

1978

4129

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.1

240.8

1284

2115

G40

ICD-10 Finland

Epilepsy

6.1

240.7

577

478

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

240.7

1147

1755

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

240.3

5125

15308

N06AX03

ATC

mianserin; oral

2.2

239.6

2478

5751

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

239.4

5243

15778

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

239.4

4482

12881

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

239.1

3293

8547

JAH01

NOMESCO Finland

Laparoscopy

2.2

238.9

2506

5851

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

238.1

2768

6738

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

237.3

4542

13141

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.4

237.0

1926

4007

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

235.5

2906

7240

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

235.3

44459

198323

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

235.2

13998

52643

N05AF03

ATC

chlorprothixene; systemic

2.7

235.0

1519

2805

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

234.4

1153

1802

M03BX01

ATC

baclofen; systemic

3.5

234.2

1046

1530

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.4

234.1

2024

4337

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

234.0

944

1281

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

233.9

6172

19523

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.8

233.7

920

1225

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

233.1

1858

3829

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

233.0

939

1273

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

232.6

4283

12243

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

232.6

6088

19216

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

231.8

1042

1531

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

231.4

3273

8574

S22.3

ICD-10 Finland

Fracture of rib

1.9

231.3

3678

10030

P20

ICPC

Memory disturbance

1.7

230.9

5535

17069

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

230.5

1608

3095

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.2

230.4

633

610

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

230.2

1172

1874

D09

ICPC

Nausea

2.1

229.6

2760

6806

XKD00

NOMESCO Finland

Uroflowmetry

1.6

229.6

7491

24945

R03BA05

ATC

fluticasone; inhalant

1.5

229.3

10574

37902

J01CA08

ATC

pivmecillinam; oral

1.3

229.0

23049

94176

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

228.6

6382

20472

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

228.5

2455

5787

U02

ICPC

Urinary frequency/urgency

1.6

228.5

7422

24689

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

228.2

1840

3813

R62.0

ICD-10 Finland

Delayed milestone

38.9

227.4

248

F10.24

ICD-10 Finland

Alcohol depence active use

3.7

227.4

920

1251

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.0

226.4

830

1044

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

226.2

3130

8134

WX882

NOMESCO Finland

High dependency care

2.7

225.6

1482

2761

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

225.1

4106

11699

A07AA02

ATC

nystatin; oral

2.0

224.8

2889

7307

N06AA10

ATC

nortriptyline; systemic

3.1

224.7

1179

1922

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

224.5

23177

94972

SFA20

NOMESCO Finland

Two-surface restoration

1.3

224.4

37638

164726

L03AA13

ATC

pegfilgrastim; parenteral

2.3

224.3

2156

4846

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

224.2

3732

10330

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

224.1

3355

8963

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

223.9

16151

62665

R50.8

ICD-10 Finland

Other specified fever

8.5

223.3

419

249

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

223.2

4075

11614

SPAT1104

SPAT

Monitoring of emergency patient

1.9

223.1

3346

8943

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

223.0

5240

16066

R60.1

ICD-10 Finland

Generalized oedema

7.8

222.9

441

284

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

221.8

2212

5052

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.6

221.8

925

1287

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

221.5

1749

3587

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

221.3

5126

15654

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

220.8

3292

8781

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

220.6

1734

3548

A99

ICPC

Disease/condition unspecnature/site

1.7

220.0

4880

14724

U07

ICPC

Urine symptom/complaint other

1.8

219.5

3717

10343

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.4

219.3

1024

1545

K92.1

ICD-10 Finland

Melaena

2.1

218.5

2591

6353

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

217.9

3235

8615

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

217.7

3873

10946

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

217.7

5744

18152

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

217.4

1363

2473

J05AB01

ATC

aciclovir; systemic

1.4

217.1

12142

45076

R01AD08

ATC

fluticasone; nasal

1.4

217.0

16983

66697

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

216.9

3683

10257

Z01.2

ICD-10 Finland

Dental examination

1.3

216.6

28688

121488

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

216.6

3832

10812

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

216.5

3130

8259

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

216.3

1268

2213

G50.1

ICD-10 Finland

Atypical facial pain

3.4

215.9

1001

1503

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

215.6

15642

60683

B01AF02

ATC

apixaban; oral

1.6

214.1

5501

17262

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.9

214.1

1283

2268

ZXA10

NOMESCO Finland

Bilateral

1.5

213.7

9584

34120

B01AB10

ATC

tinzaparin; parenteral

1.7

213.4

5082

15630

R21

ICPC

Throat symptom/complaint

1.4

213.4

13431

50881

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

213.2

12467

46631

L04AX01

ATC

azathioprine; systemic

2.1

212.6

2414

5818

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

212.6

6358

20720

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.2

212.5

2294

5417

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

212.2

8172

28195

C10AA05

ATC

atorvastatin; oral

1.3

212.1

21153

86076

B03XA02

ATC

darbepoetin alfa; parenteral

3.3

212.0

1010

1545

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

211.7

11978

44533

L08

ICPC

Shoulder symptom/complaint

1.4

211.5

11750

43542

R96

ICPC

Asthma

1.7

211.2

5018

15422

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

210.9

8531

29734

I50.0

ICD-10 Finland

Congestive heart failure

1.9

210.7

3165

8461

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

210.6

2656

6667

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.4

210.4

969

1448

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

210.3

3048

8048

R03BA02

ATC

budesonide; inhalant

1.4

209.7

10089

36398

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

209.1

2090

4777

A10AE04

ATC

insulin glargine; parenteral

1.7

208.6

4915

15070

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.8

208.4

822

1096

M01AX17

ATC

nimesulide; oral

1.4

208.3

12127

45299

R35

ICD-10 Finland

Polyuria

1.9

208.1

3288

8940

L02

ICPC

Back symptom/complaint

1.6

208.1

5682

18103

H01

ICPC

Ear pain/earache

1.6

208.1

6802

22628

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

207.8

1645

3377

K07

ICPC

Swollen ankles/oedema

2.3

207.5

2014

4545

A41.8

ICD-10 Finland

Other specified sepsis

3.6

207.4

880

1240

N89

ICPC

Migraine

2.2

207.3

2134

4939

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

207.3

12578

47320

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

207.1

5384

16941

K92.0

ICD-10 Finland

Haematemesis

2.8

206.9

1262

2254

R518, ,

ICD-10 Finland

+∞

206.6

265

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.4

205.7

1774

3795

-1, ,

NOMESCO Finland

1.3

205.6

20663

84087

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

205.6

3864

11102

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

205.5

2161

5046

G04CA02

ATC

tamsulosin; oral

1.4

205.4

11234

41487

N88

ICPC

Epilepsy

8.2

204.9

392

240

XQ800

NOMESCO Finland

Prick test

1.7

204.2

4229

12505

KMAK, ,

NOMESCO Finland

1.3

204.2

32334

139761

L29

ICPC

Musculoskeletal sympt/complt other

1.7

203.9

4481

13476

N06AA12

ATC

doxepin; systemic

2.0

203.7

2520

6279

L15

ICPC

Knee symptom/complaint

1.4

203.1

12978

49235

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

202.4

2625

6657

N04BC05

ATC

pramipexole; oral

1.8

202.1

3629

10280

F05.9

ICD-10 Finland

Delirium, unspecified

3.3

202.1

980

1517

130

Kela drug reimbursment

Malignant tumour

1.7

202.0

4149

12237

C10AA01

ATC

simvastatin; oral

1.3

202.0

20383

82951

G44.0

ICD-10 Finland

Cluster headache syndrome

4.2

201.9

694

827

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

201.6

2951

7817

SPAT1211

SPAT

Application of soft bandage

1.7

201.2

4609

14019

H57.1

ICD-10 Finland

Ocular pain

2.2

200.9

2081

4829

N05BE01

ATC

buspirone; oral

2.5

200.2

1604

3312

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

4.4

200.1

651

739

K08.3

ICD-10 Finland

Retained dental root

1.8

199.9

3892

11299

R31

ICD-10 Finland

Unspecified haematuria

1.7

199.9

4874

15075

N06AB05

ATC

paroxetine; oral

1.9

199.7

3293

9078

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.4

199.6

923

1383

U04

ICPC

Incontinence urine

2.1

199.6

2341

5713

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

199.2

4273

12760

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

199.1

2130

5009

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.8

198.9

1250

2271

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

198.7

1399

2705

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

198.4

7312

24966

WX872

NOMESCO Finland

Intensive care

2.0

198.2

2505

6291

H53.2

ICD-10 Finland

Diplopia

2.4

198.1

1613

3357

G44.8

ICD-10 Finland

Other specified headache syndromes

3.4

197.9

898

1328

N05AN01

ATC

lithium; oral

2.6

197.9

1398

2708

R5110, ,

SPAT

1.9

197.8

3018

8108

D02

ICPC

Abdominal pain epigastric

1.9

197.5

3272

9033

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

197.4

1651

3480

SPAT1252

SPAT

Overall medication plan or its review

1.9

197.3

3158

8620

SPAT1283

SPAT

Restricted health certificate

1.4

197.1

11308

42083

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

54.2

197.1

205

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

196.8

1055

1743

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

196.7

4669

14335

L14

ICPC

Leg/thigh symptom/complaint

1.7

196.5

4050

11954

N05BA09

ATC

clobazam; oral

7.0

196.3

422

305

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

196.0

3429

9633

T90

ICPC

Diabetes non-insulin dependent

1.4

195.9

11718

43924

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.4

195.8

1689

3613

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

195.8

7148

24352

E66.8

ICD-10 Finland

Other obesity

1.9

194.7

3109

8480

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

194.6

15070

58913

UJD02

NOMESCO Finland

Gastroscopy

2.1

193.5

2350

5812

Z00.8

ICD-10 Finland

Other general examinations

1.7

193.2

4391

13322

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

192.5

1285

2414

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.1

192.3

684

839

P74

ICPC

Anxiety disorder/anxiety state

2.0

191.7

2571

6599

R40.2

ICD-10 Finland

Coma, unspecified

5.6

191.3

490

438

A10AC01

ATC

insulin (human); parenteral

1.7

190.9

3907

11507

L86

ICPC

Back syndrome with radiating pain

1.9

190.7

3097

8492

M02AA07

ATC

piroxicam; topical

1.3

189.8

19183

77935

D10

ICPC

Vomiting

1.8

189.5

3657

10584

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

189.3

2394

6013

R07.0

ICD-10 Finland

Pain in throat

1.7

189.2

4108

12304

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.6

189.1

805

1137

M05BX04

ATC

denosumab; parenteral

2.0

189.1

2472

6286

I49.5

ICD-10 Finland

Sick sinus syndrome

2.4

188.9

1557

3259

M54.1

ICD-10 Finland

Radiculopathy

2.1

188.7

2076

4937

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

188.5

2822

7530

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

188.2

6977

23835

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

187.4

13761

53304

J20

ICD-10 Finland

Acute bronchitis

1.6

187.0

5507

17853

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

186.5

44804

202796

P99

ICPC

Psychological disorders other

2.3

185.3

1723

3814

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

185.3

1104

1945

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

185.0

1592

3401

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

184.7

866

1310

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

184.1

1100

1941

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

183.6

2423

6181

G04BD12

ATC

mirabegron; oral

1.6

183.4

5277

17008

M01AH02

ATC

rofecoxib; oral

1.5

183.2

6078

20255

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.9

183.1

1101

1950

M54.3

ICD-10 Finland

Sciatica

1.8

182.2

3043

8418

G43.8

ICD-10 Finland

Other migraine

3.2

181.8

915

1452

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

181.4

6741

23028

L16

ICPC

Ankle symptom/complaint

1.5

180.7

6219

20891

R10.0

ICD-10 Finland

Acute abdomen

2.2

180.2

1760

3981

A07AA09

ATC

vancomycin; oral

3.8

180.1

717

963

S80.0

ICD-10 Finland

Contusion of knee

1.7

179.9

4081

12367

207

Kela drug reimbursment

Chronic arrhythmias

1.5

179.9

6651

22695

N06AX05

ATC

trazodone; oral

2.5

179.3

1384

2805

M01AC06

ATC

meloxicam; systemic, rectal

1.3

179.1

19709

80868

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.3

178.9

1666

3690

R50.0

ICD-10 Finland

Fever with chills

65.3

178.7

182

L04AD01

ATC

ciclosporin; systemic

2.9

178.6

1021

1755

R03AC03

ATC

terbutaline; inhalant

1.5

178.4

7587

26647

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

177.7

5923

19752

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

177.0

4372

13553

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

176.7

5640

18622

R06.4

ICD-10 Finland

Hyperventilation

3.1

176.2

917

1487

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

175.8

16738

67291

SFA30

NOMESCO Finland

Three-surface restoration

1.3

175.7

24681

104440

J46

ICD-10 Finland

Status asthmaticus

2.4

175.3

1453

3049

TGC00

NOMESCO Finland

Bronchial lavation

2.6

175.2

1227

2365

I95.9

ICD-10 Finland

Hypotension, unspecified

3.7

175.2

703

950

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

175.1

1566

3405

A02BC04

ATC

rabeprazole; oral

1.6

174.9

4550

14293

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

174.4

2413

6261

R01AD12

ATC

fluticasone furoate; nasal

1.3

174.1

19093

78240

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

174.1

1485

3159

G43

ICD-10 Finland

Migraine

1.8

173.9

3043

8542

N05AD01

ATC

haloperidol; systemic

2.3

173.8

1558

3391

M10.9

ICD-10 Finland

Gout, unspecified

1.8

173.8

3057

8596

J01DA09

ATC

[U] cefadroxil

1.3

173.5

15385

61205

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

172.9

2982

8332

A11CC03

ATC

alfacalcidol; systemic

2.7

172.9

1151

2159

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

172.8

20132

83141

K07.60

ICD-10 Finland

Snapping jaw

1.8

172.6

2901

8039

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

171.4

2312

5944

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.4

171.4

1428

3004

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

171.1

6527

22405

JN6AD

NOMESCO Finland

CT of torso and neck

3.4

170.9

779

1156

N05AB03

ATC

perphenazine; systemic, rectal

2.2

170.4

1811

4245

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

170.4

2369

6157

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

170.1

862

1374

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

170.0

7267

25533

SGA01

NOMESCO Finland

Emergency treatment

1.4

169.5

9616

35618

N02CC03

ATC

zolmitriptan; nasal, oral

1.8

169.4

2893

8057

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

169.2

886

1442

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.5

169.0

1298

2624

I20.09

ICD-10 Finland

Unstable angina

1.9

168.9

2436

6413

L04AD02

ATC

tacrolimus; systemic

4.0

168.7

614

768

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.4

168.5

1462

3135

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

168.2

1779

4161

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

168.0

2247

5758

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

167.9

2253

5780

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

167.8

2431

6409

N02CC04

ATC

rizatriptan; oral

1.8

167.3

3085

8799

F34.1

ICD-10 Finland

Dysthymia

2.1

167.3

2001

4917

R04.0

ICD-10 Finland

Epistaxis

1.7

167.0

3492

10338

J05AB11

ATC

valaciclovir; oral

1.5

166.6

7507

26643

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.3

166.5

1504

3285

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.5

166.4

728

1049

K08.80

ICD-10 Finland

Toothache NOS

1.6

166.1

4935

16012

R63.1

ICD-10 Finland

Polydipsia

14.2

166.1

238

M54

ICD-10 Finland

Dorsalgia

1.5

166.1

6971

24397

M05BA04

ATC

alendronic acid; oral

1.7

165.7

3531

10509

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.3

165.6

1584

3549

L04

ICPC

Chest symptom/complaint

1.8

165.5

3182

9191

R03BA01

ATC

beclometasone; inhalant

1.5

165.4

7355

26036

PA6AD

NOMESCO Finland

CT of neck arteries

2.4

164.8

1383

2919

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

164.4

2690

7388

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

164.2

1728

4033

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.7

164.2

662

898

R54

ICD-10 Finland

Senility

19.5

164.2

210

C01CA24

ATC

epinephrine; parenteral

1.7

164.1

3472

10311

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

164.0

1188

2331

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.1

163.9

589

729

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

163.9

6039

20569

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

7.2

162.7

342

240

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.7

162.6

660

900

N05AH02

ATC

clozapine; systemic

2.7

162.5

1071

1998

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

162.1

1760

4161

R29

ICPC

Respiratory symptom/complaint other

1.7

162.1

3526

10553

L05

ICPC

Flank/axilla symptom/complaint

1.8

162.1

3004

8580

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.1

161.8

842

1365

SPAT1167

SPAT

Insertion of urinary catheter

2.4

161.5

1320

2751

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

9.3

161.4

286

155

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

160.8

5144

16976

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

160.4

1606

3670

G72.8

ICD-10 Finland

Other specified myopathies

3.4

160.4

743

1115

N06AX22

ATC

agomelatine; oral

2.4

160.3

1344

2835

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

160.3

3790

11604

R68.8

ICD-10 Finland

Other specified general symptoms and signs

5.2

160.2

444

432

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

160.2

2474

6666

L13

ICPC

Hip symptom/complaint

1.4

160.1

8712

32005

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

159.5

2530

6878

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

354.6

159.2

212

S70.0

ICD-10 Finland

Contusion of hip

2.1

159.0

1802

4335

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

158.8

1416

3074

R06AX27

ATC

desloratadine; oral

1.3

158.7

17126

69857

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

158.3

2009

5048

M35.7

ICD-10 Finland

Hypermobility syndrome

3.1

158.3

824

1336

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

158.0

3770

11569

N19

ICD-10 Finland

Unspecified kidney failure

2.3

158.0

1509

3379

C08CA13

ATC

lercanidipine; oral

1.5

157.8

6505

22669

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.1

157.7

808

1297

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

157.6

1002

1832

E000001, ,

ATC

1.4

157.4

11252

43248

WVA20

NOMESCO Finland

Medicine administration

2.4

156.7

1310

2760

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

156.5

3954

12318

C08DA01

ATC

verapamil; systemic

2.0

156.3

1918

4759

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

156.2

1084

2079

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

156.0

1986

4996

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

155.8

792

1265

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

155.2

669

954

R01AD58

ATC

fluticasone, combinations; nasal

1.3

155.0

14597

58418

ZXD35

NOMESCO Finland

Usual procedure

2.2

154.7

1651

3876

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

154.6

61791

293656

Z94.0

ICD-10 Finland

Kidney transplant status

3.7

154.4

619

836

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

154.1

2929

8427

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

153.9

1906

4745

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

153.8

5654

19234

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.7

153.8

472

508

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

153.7

1990

5038

A03FA02

ATC

cisapride; oral, rectal

1.7

153.6

3552

10807

U05

ICPC

Urination problems other

1.9

153.2

2271

6033

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.7

152.8

625

857

N02CC07

ATC

frovatriptan; oral

1.9

152.8

2207

5811

7807A

ICD-9 Finland

General symptoms, Malaise and fatigue

+∞

152.7

196

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

152.5

3356

10073

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

152.1

13052

51528

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

152.1

931

1666

A10BA02

ATC

metformin; oral

1.3

152.0

14177

56634

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

151.0

3960

12450

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

150.9

1235

2575

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

150.8

5317

17922

XA400

NOMESCO Finland

EEG

6.2

150.1

354

288

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

150.0

1327

2870

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

149.9

2743

7801

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

149.6

4085

12973

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.8

149.1

930

1682

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

148.9

1882

4721

R06.5

ICD-10 Finland

Mouth breathing

1.6

148.3

4700

15466

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

148.3

1556

3627

P18

ICPC

Medication abuse

5.1

148.0

413

405

A05

ICPC

Feeling ill

1.7

147.1

3567

10988

R25.2

ICD-10 Finland

Cramp and spasm

2.4

147.1

1246

2641

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

147.0

5653

19404

T74.1

ICD-10 Finland

Physical abuse

2.5

146.9

1132

2292

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

146.8

4466

14555

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.5

146.0

651

951

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

146.0

690

1050

N05BA02

ATC

chlordiazepoxide; systemic

2.5

145.9

1138

2318

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

145.9

1135

2309

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

145.6

1133

2305

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.2

145.3

717

1123

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

145.3

2073

5434

A01AB09

ATC

miconazole; local oral

1.6

145.2

4226

13628

U01

ICPC

Dysuria/painful urination

1.6

145.1

3940

12492

J01CF05

ATC

flucloxacillin; systemic

1.7

145.0

3140

9379

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

145.0

5776

19969

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

145.0

4894

16332

R4110, ,

SPAT

1.6

144.8

4109

13170

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

144.6

13375

53315

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.0

144.5

536

681

K04.08

ICD-10 Finland

Other specified pulpit

1.6

144.5

4326

14045

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

144.2

4636

15301

L84

ICPC

Back syndrome without radiat pain

1.9

144.0

2356

6467

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.8

143.8

564

749

D07AA02

ATC

hydrocortisone; topical

1.4

143.8

7887

28971

R12

ICD-10 Finland

Heartburn

1.6

143.8

4195

13536

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

9.1

143.7

258

143

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.2

143.7

1501

3492

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

143.6

1120

2281

J45

ICD-10 Finland

Asthma

1.5

143.5

5407

18476

R04.2

ICD-10 Finland

Haemoptysis

2.2

143.3

1526

3578

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.6

143.2

1040

2043

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

142.7

3412

10469

RS221, ,

NOMESCO Finland

3.1

142.7

759

1248

K04.0

ICD-10 Finland

Pulpitis

1.5

142.6

5371

18351

WW200

NOMESCO Finland

Immunization

2.2

142.6

1419

3234

C82.1

ICD-10 Finland

Follicular lymphoma grade II

7.1

142.6

303

216

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

141.9

2015

5272

M89.0

ICD-10 Finland

Algoneurodystrophy

4.2

141.5

491

590

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

141.5

1082

2182

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

141.4

6024

21106

S21

ICPC

Skin texture symptom/complaint

1.4

141.4

7237

26253

SPAT1360

SPAT

Extensive global examination

1.7

141.3

3395

10431

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

141.2

11991

47202

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

140.6

3533

10982

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

140.2

4330

14157

R50.1

ICD-10 Finland

Persistent fever

140.3

140.1

195

M54.8

ICD-10 Finland

Other dorsalgia

1.9

139.5

2269

6215

D12

ICPC

Constipation

2.1

139.4

1600

3867

A06AH03

ATC

naloxegol; oral

3.3

139.0

652

987

A87.9

ICD-10 Finland

Viral meningitis, unspecified

4.7

139.0

426

458

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

138.9

1229

2658

S76

ICPC

Skin infection other

1.8

138.6

2550

7261

205

Kela drug reimbursment

Chronic hypertension

1.3

138.5

12396

49147

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

138.5

1923

4992

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

138.4

4071

13158

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

138.3

2112

5665

C09CA01

ATC

losartan; oral

1.3

138.3

12356

48975

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.8

138.1

851

1529

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.2

137.7

1411

3256

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

137.6

1567

3775

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.8

137.6

876

1603

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

137.4

14174

57286

Z50.1

ICD-10 Finland

Other physical therapy

1.8

136.5

2474

7012

SPAT1101

SPAT

Orthostatic test

2.0

136.5

1718

4302

L04AX03

ATC

methotrexate; systemic

1.5

136.1

4880

16494

XCK00

NOMESCO Finland

Perimetry

1.7

135.9

2904

8640

A06

ICPC

Fainting/syncope

3.2

135.8

664

1034

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.6

135.8

939

1798

N02CC05

ATC

almotriptan; oral

1.9

135.6

2109

5692

P01BA02

ATC

hydroxychloroquine; oral

1.6

135.3

3986

12886

K90

ICPC

Stroke/cerebrovascular accident

2.4

135.2

1130

2380

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.1

133.9

373

365

N02CC06

ATC

eletriptan; oral

1.9

133.9

1909

5001

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

133.8

24566

106265

ZY000

NOMESCO Finland

Hospital inpatient

3.0

133.2

737

1242

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

133.1

1389

3230

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

132.9

908

1727

K80

ICPC

Cardiac arrhythmia NOS

1.6

132.9

3758

12028

A10AE05

ATC

insulin detemir; parenteral

1.7

132.6

2648

7726

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

132.2

1449

3438

A97

ICPC

No disease

1.3

132.1

9595

36862

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

7.5

131.9

267

178

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

131.7

1097

2307

UDC00

NOMESCO Finland

Ear microscopy

1.6

131.6

3738

11975

B01AB04

ATC

dalteparin; parenteral

1.8

131.5

2473

7088

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.4

131.3

1054

2177

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

131.2

1484

3566

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

130.8

1821

4730

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.3

130.4

608

917

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

130.3

957

1891

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

129.5

1043

2158

R03BA08

ATC

ciclesonide; inhalant

1.5

129.5

4406

14716

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

5.8

129.5

321

277

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

129.3

766

1345

J01MA06

ATC

norfloxacin; oral

1.4

129.2

6305

22649

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

129.0

1152

2502

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.2

128.8

628

976

S01

ICPC

Pain/tenderness of skin

1.8

128.6

2233

6244

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

128.6

4770

16231

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

128.4

3847

12482

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

128.0

1506

3675

N06AG02

ATC

moclobemide; oral

1.9

127.5

2035

5538

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

127.5

4190

13885

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

127.5

2699

8006

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5.3

127.4

347

332

N29

ICPC

Neurological sympt/complt other

2.6

127.3

909

1770

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

127.3

1643

4153

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

127.2

16002

66212

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.4

126.9

1064

2244

C09AA02

ATC

enalapril; systemic

1.4

126.8

8953

34227

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.9

126.6

477

614

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

6.4

126.5

290

228

R81

ICPC

Pneumonia

2.0

126.2

1644

4169

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

126.2

2107

5819

N06BA04

ATC

methylphenidate; oral

1.9

126.0

1884

5017

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.4

125.8

1075

2288

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

125.3

524

731

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

125.3

1385

3297

G40.89

ICD-10 Finland

Other epilepsy

6.8

125.1

272

200

R09

ICPC

Sinus symptom/complaint

1.5

125.0

4405

14821

Z29

ICPC

Social problem NOS

2.3

124.7

1104

2389

D07AC13

ATC

mometasone; topical

1.3

124.5

15911

65930

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

124.5

1080

2315

SPAT1053

SPAT

Memory test

1.5

124.3

5514

19447

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

124.2

1361

3228

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

124.2

1944

5256

F32

ICD-10 Finland

Depressive episode

1.7

123.7

3013

9284

RS220, ,

NOMESCO Finland

3.0

123.5

665

1102

V03AE01

ATC

polystyrene sulfonate; oral

3.3

123.3

596

921

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

123.3

2706

8107

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

123.2

3047

9425

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

123.2

2617

7769

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

122.9

2180

6136

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

122.8

969

1985

M02AA10

ATC

ketoprofen; topical

1.4

122.7

7829

29441

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

122.7

2854

8687

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

122.6

4272

14338

N07

ICPC

Convulsion/seizure

11.7

122.2

191

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

122.1

733

1297

N04AA02

ATC

biperiden; systemic

2.5

122.1

928

1866

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

122.0

9864

38465

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

120.9

445

562

K78

ICPC

Atrial fibrillation/flutter

1.6

120.6

3001

9296

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

120.5

1815

4844

R06.2

ICD-10 Finland

Wheezing

1.8

120.3

2224

6340

P16

ICPC

Acute alcohol abuse

2.6

120.1

881

1740

S10

ICPC

Boil/carbuncle

1.7

120.0

2901

8920

A27

ICPC

Fear of other disease NOS

1.8

119.9

2220

6330

M01AB55

ATC

diclofenac, combinations; oral

1.7

119.8

2899

8915

E87.5

ICD-10 Finland

Hyperkalaemia

2.8

119.7

728

1298

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

119.7

22217

95903

SPAT1172

SPAT

Guidance concerning hydration

2.5

119.7

901

1803

B02.9

ICD-10 Finland

Zoster without complication

1.7

118.7

2876

8847

RS222, ,

NOMESCO Finland

3.2

118.6

581

906

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.7

118.6

300

265

S04

ICPC

Lump/swelling localized

1.4

118.4

5361

18975

ZX112

NOMESCO Finland

Subcutaneous

2.4

118.2

970

2025

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.8

118.2

2077

5829

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.8

118.0

751

1374

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

117.7

895

1800

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

117.6

2297

6655

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

117.5

7661

28895

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.8

117.5

749

1372

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.7

117.4

775

1447

SPAT1325

SPAT

Vaccination

1.2

117.4

17520

73825

J45.8

ICD-10 Finland

Mixed asthma

2.0

117.4

1482

3715

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.5

117.0

882

1766

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

116.9

1188

2731

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

116.9

4893

17053

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

116.8

2982

9298

XF606

NOMESCO Finland

Ortostatic test

5.1

116.8

328

324

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.5

116.6

376

424

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

116.5

1971

5465

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

116.5

2373

6960

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

116.4

3791

12529

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

116.4

1099

2448

C10AC01

ATC

colestyramine; oral

2.1

116.4

1283

3051

PA2AD

NOMESCO Finland

CT angiography of brain

3.9

116.3

442

573

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.7

116.1

777

1462

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

116.0

2649

8020

G40.10

ICD-10 Finland

Simple partial seizures

4.3

115.9

391

459

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.9

115.7

674

1172

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

115.7

5836

21069

C08CA05

ATC

nifedipine; systemic

1.7

115.6

2762

8464

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.2

115.6

588

940

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.8

115.6

448

590

RD210, ,

NOMESCO Finland

2.5

115.5

894

1814

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

115.5

1435

3575

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

115.4

1517

3860

N03AB02

ATC

phenytoin; systemic

3.4

115.3

519

764

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

115.2

2226

6429

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

115.2

4399

15048

SPAT1058

SPAT

PEF monitoring instruction

1.5

114.9

3857

12834

A02BA04

ATC

nizatidine; systemic

1.6

114.6

3359

10834

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

114.4

2106

5994

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

114.4

10885

43380

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

114.4

7723

29283

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

114.3

1410

3503

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.4

114.3

992

2127

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

6.3

114.1

264

210

P19

ICPC

Drug abuse

3.1

114.1

582

932

X57

ICD-10 Finland

Unspecified privation

2.2

114.0

1105

2490

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

113.9

1257

2990

H92.0

ICD-10 Finland

Otalgia

1.6

113.9

3180

10138

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

113.8

6778

25181

G04BD08

ATC

solifenacin; oral

1.6

113.5

2774

8551

F45.0

ICD-10 Finland

Somatization disorder

6.0

113.4

272

226

C02AC05

ATC

moxonidine; oral

1.8

113.4

1899

5248

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

8.2

113.2

216

132

J01FA15

ATC

telithromycin; oral

1.5

113.2

4941

17357

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.8

113.2

701

1263

T82

ICPC

Obesity

1.8

112.8

2095

5978

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

112.8

3301

10643

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

112.7

1706

4561

D07AD01

ATC

clobetasol; topical

1.3

112.5

8417

32413

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

112.5

1132

2592

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.7

112.2

757

1431

S20.2

ICD-10 Finland

Contusion of thorax

1.7

112.1

2543

7685

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

111.7

894

1844

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

111.6

1685

4500

OAB93, ,

SPAT

1.6

111.5

3211

10313

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

111.4

2465

7399

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.1

111.0

1213

2874

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

110.9

5363

19205

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

110.6

2241

6562

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.1

110.4

1251

3008

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

110.4

1286

3126

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.0

110.2

1435

3638

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.0

110.2

621

1059

EBA30

NOMESCO Finland

Extraction of root of tooth

1.7

110.1

2603

7953

SAA04

NOMESCO Finland

Special examination of mouth

1.6

110.1

2771

8606

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

110.1

727

1358

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

109.8

2446

7354

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.5

109.7

844

1708

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

109.5

1299

3180

J01DA06

ATC

[U] cefuroxime

1.4

109.5

7468

28347

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

109.4

2045

5847

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

109.4

1213

2891

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

109.1

3066

9788

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

109.1

2191

6399

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.4

109.0

892

1860

SPAT1251

SPAT

Organisation of medication

1.9

109.0

1569

4123

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

108.9

1268

3081

XG466

NOMESCO Finland

Sleep oxymetry

2.0

108.8

1414

3582

Z72.2

ICD-10 Finland

Drug use

4.3

108.7

365

427

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

108.6

1449

3706

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.4

108.5

898

1883

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

108.3

3921

13257

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

108.3

3115

9999

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

108.3

1671

4496

N28

ICPC

Limited function/disability (N)

2.7

108.1

703

1302

U71

ICPC

Cystitis/urinary infection other

1.6

108.1

3081

9869

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

107.9

3186

10291

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.9

107.7

638

1121

Z08

ICPC

Social welfare problem

2.8

107.6

670

1211

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

107.6

2697

8366

N06DX01

ATC

memantine; oral

1.7

107.6

2522

7688

A12AA04

ATC

calcium carbonate; oral

2.7

107.6

701

1300

K29

ICPC

Cardiovascular sympt/complt other

1.8

107.4

1807

5000

R1250

NOMESCO Finland

Evaluation of functional capability

2.2

107.2

1064

2422

R63.0

ICD-10 Finland

Anorexia

6.7

107.0

236

177

N18

ICPC

Paralysis/weakness

2.5

106.9

797

1587

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.1

106.9

1211

2911

A06AC51

ATC

ispaghula, combinations; oral

1.7

106.9

2214

6523

R06AX22

ATC

ebastine; oral

1.3

106.8

9208

36168

C03AA03

ATC

hydrochlorothiazide; oral

1.5

106.6

3794

12779

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

106.5

3359

11017

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

106.4

1256

3068

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.4

106.4

913

1947

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

106.3

1096

2535

GEA00

NOMESCO Finland

Mediastinoscopy

6.6

106.2

238

182

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

106.1

1371

3466

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.7

106.1

434

596

WX320

NOMESCO Finland

Spinalanesthesy

1.3

106.1

12119

49393

WX704

NOMESCO Finland

Intubation

1.5

106.0

4061

13893

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

6.7

106.0

233

174

L60.0

ICD-10 Finland

Ingrowing nail

1.7

105.9

2309

6901

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

105.7

4414

15365

SPAT1139

SPAT

Nutrition survey

1.9

105.6

1484

3866

L09

ICPC

Arm symptom/complaint

1.7

105.6

2326

6972

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.4

105.4

852

1766

XA402

NOMESCO Finland

ENMG

2.1

105.3

1168

2784

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

105.1

2574

7937

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.3

104.9

977

2163

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

104.9

1372

3484

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

104.8

1247

3056

B02AA02

ATC

tranexamic acid; systemic

1.3

104.8

7540

28843

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

104.7

1041

2371

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.4

104.7

279

261

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

104.3

11266

45582

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

104.1

2458

7507

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.3

104.0

498

765

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

104.0

1317

3305

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

103.7

3935

13432

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

103.6

1247

3069

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

103.6

3109

10078

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

103.6

1262

3121

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.5

103.6

456

661

U29

ICPC

Urinary symptom/complaint other

2.0

103.5

1296

3238

N05CD08

ATC

midazolam; nasal, systemic

2.3

103.2

963

2134

JAH00

NOMESCO Finland

Laparotomy

2.1

103.2

1219

2979

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.5

103.1

784

1577

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

103.1

1142

2721

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.8

103.0

628

1122

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

102.6

1011

2294

137

Kela drug reimbursment

Uraemia requiring dialysis

3.6

102.6

427

594

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.0

102.6

377

476

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

102.5

1054

2436

C05AA08

ATC

fluocortolone; rectal, topical

1.4

102.4

6656

25055

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

102.3

1634

4447

R30.0

ICD-10 Finland

Dysuria

1.7

102.0

2020

5874

SPAT1285

SPAT

Provision of consultation response

1.7

101.9

2466

7580

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

101.7

837

1750

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.2

101.5

1039

2396

N18.0

ICD-10 Finland

End-stage renal disease

3.3

101.5

490

757

-50

ICPC

Medication/prescr/renewal

1.8

101.5

1816

5123

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.1

101.0

1118

2663

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

100.9

1146

2758

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

100.9

3021

9788

SPAT1281

SPAT

Other administrative function

1.5

100.6

3883

13301

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

4.4

100.4

331

381

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.6

100.3

314

345

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

100.3

2639

8287

D07AB08

ATC

desonide; topical

1.4

100.0

5514

20196

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

99.8

5791

21394

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

99.8

1291

3265

R07.2

ICD-10 Finland

Precordial pain

2.3

99.8

921

2031

R5599

NOMESCO Finland

Other rehabilitation service

2.0

99.6

1248

3119

SPAT1050

SPAT

Extensive neurological examination

2.3

99.6

936

2081

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

99.5

1522

4082

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

99.5

1495

3986

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

99.4

1009

2319

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.4

99.4

848

1804

N06AA06

ATC

trimipramine; systemic

2.1

99.4

1075

2537

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

99.3

1380

3582

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.3

99.2

901

1973

K04

ICPC

Palpitations/awareness of heart

1.6

98.9

2436

7521

N76.0

ICD-10 Finland

Acute vaginitis

1.5

98.9

3332

11087

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.2

98.8

987

2253

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

98.8

1918

5545

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

700

513

6.89

322.13

2.5

2.4

51.86

50.47

umol/l

0.38

619

432

(3025941) Bacteria identified in Stool by Culture

5302

14686

1.87

321.62

1.3

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

1322

1833

3.66

318.67

1.6

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2358

4688

2.57

318.65

2.4

2.0

0.00

g/l

0.16

2144

4254

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

1322

1834

3.66

318.44

1.6

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3091

7001

2.26

317.69

2.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1056

1227

4.36

316.23

2.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1056

1227

4.36

316.23

2.0

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1056

1227

4.36

316.23

2.0

1.3

—

(3011412) CD3 cells [#/volume] in Blood

1258

1691

3.77

315.83

2.6

2.2

1.21

1.20

e9/l

0.15

1123

1495

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2324

4620

2.57

314.05

2.4

2.0

0.00

g/l

-0.00

2137

4239

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

830

778

5.39

310.16

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1394

2054

3.45

309.10

1.1

35.78

17.44

au/ml

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3186

7398

2.21

308.97

2.7

2.2

92.58

92.70

0.09

3066

7059

(3043409) Potassium [Moles/volume] in Arterial blood

2709

5852

2.37

308.97

4.7

4.2

3.86

3.89

mmol/l

2.91

2680

5811

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

2586

4048

3.28

307.65

1.3

276.16

248.30

u/ml

3.86

1688

2596

(3048689) Calprotectin [Mass/mass] in Stool

11050

33174

1.79

307.65

2.5

2.4

139.93

127.48

ug/g

2.02

8751

26343

(3002385) Erythrocyte distribution width [Ratio]

56405

254575

1.46

307.65

23.4

12.0

14.70

14.99

3.71

55761

249361

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7335

22205

1.73

307.65

4.1

4.0

29.32

23.91

ug/l

0.42

5929

17545

(40768797) Stomach Pathology biopsy report

11183

32125

1.88

307.65

1.3

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

18083

47099

2.22

307.65

3.0

2.3

5.86

5.71

e6/l

0.64

16502

41568

(3004588) Protein electrophoresis panel - Serum or Plasma

5863

12043

2.56

307.65

2.4

2.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3472

6118

2.93

307.65

1.9

1.6

0.23

g/l

1.63

3301

5814

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4577

10518

2.26

307.65

9.8

9.6

24.31

24.23

mmol/l

0.79

4438

10184

(3013650) Neutrophils [#/volume] in Blood by Automated count

44931

149127

2.30

307.65

11.8

7.4

4.13

4.05

e9/l

9.02

40251

128931

(3012501) Base excess in Blood by calculation

2456

4223

2.98

307.65

4.3

3.6

2.40

2.49

mmol/l

0.67

1664

2749

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

10129

26485

2.06

307.65

3.5

2.3

8.29

8.30

umol/l

0.01

8714

22884

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2983

5356

2.87

307.65

2.2

1.9

11.29

10.41

mg/l

3.25

2790

5021

(3006315) Basophils [#/volume] in Blood

40253

127962

2.26

307.65

7.3

5.2

0.04

e9/l

3.18

35696

110392

(3021879) Hepatitis B virus core Ab [Presence] in Serum

7323

21178

1.81

307.65

1.5

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

30731

105376

1.79

307.65

2.6

2.1

75.01

934.45

nmol/l

0.50

28227

95543

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5914

15008

2.06

307.65

1.3

1.2

45.37

54.39

au/ml

1.81

239

818

(3015377) Calcium [Moles/volume] in Serum or Plasma

25721

78935

1.97

307.65

3.9

2.9

2.35

2.36

mmol/l

28.02

23092

69600

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2342

3574

3.36

307.65

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3709

7449

2.57

307.65

2.1

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3348

6759

2.55

307.65

2.4

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

52978

216438

1.80

307.65

4.5

3.7

14.68

14.65

pmol/l

2.04

49155

197140

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3157

6353

2.56

307.65

2.4

2.0

2.98

2.85

g/l

8.06

2863

5668

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2672

4163

3.30

307.65

1.5

1.4

22.90

18.72

u/ml

0.51

(3002582) Erythrocytes [#/volume] in Urine

24914

70355

2.17

307.65

3.8

2.7

74.10

99.23

e6/l

1.55

19933

51924

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

6392

16502

2.03

307.65

2.4

2.3

22.30

22.63

au/ml

0.08

432

1495

(3042936) Bacteria identified in Isolate by Culture

12557

31672

2.19

307.65

2.3

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

10553

27862

2.05

307.65

2.0

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1862

3104

3.06

307.65

1.2

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

35967

131781

1.71

307.65

5.7

4.1

0.00

estimate

1.36

7687

23889

(3009343) pH of Capillary blood

5779

12783

2.37

307.65

4.1

3.2

7.42

0.03

814

1463

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

60582

267661

1.74

307.65

17.9

9.4

85.59

85.18

ml/min/173m2

3.95

52432

214592

(3018010) Neutrophils/100 leukocytes in Blood

37916

124243

2.08

307.65

7.3

5.1

57.36

56.53

30.96

36026

116416

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2990

3757

4.11

307.65

1.3

1.2

3.73

3.74

mmol/l

0.15

2814

3531

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

14363

49460

1.56

307.65

1.8

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

7191

18295

2.07

307.65

4.7

3.8

0.12

0.10

0.93

2632

4558

(3001604) Monocytes [#/volume] in Blood

40162

127697

2.26

307.65

7.3

5.1

0.58

0.57

e9/l

8.14

35653

110285

(3024561) Albumin [Mass/volume] in Serum or Plasma

34054

100940

2.28

307.65

6.1

4.1

35.35

36.26

g/l

134.15

31950

93250

(3013707) Erythrocyte sedimentation rate by Westergren method

52485

199098

2.10

307.65

4.9

3.4

12.40

10.52

mm/h

139.02

49358

184103

(3023410) Appearance of Cerebral spinal fluid

1365

1751

3.96

307.65

1.6

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4184

8382

2.59

307.65

1.9

1.7

1.53

1.47

g/l

2.75

3599

7118

(3014576) Chloride [Moles/volume] in Serum or Plasma

10893

25842

2.30

307.65

8.1

6.6

104.17

104.74

mmol/l

24.78

10886

25826

(3020891) Body temperature

3597

7663

2.42

307.65

5.6

4.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

17634

59982

1.62

307.65

2.0

1.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

5401

12719

2.22

307.65

7.9

6.6

24.57

24.51

mmol/l

0.43

5154

12057

(3019225) pH of Specimen

7502

22182

1.77

307.65

5.3

3.4

—

(3019198) Lymphocytes [#/volume] in Blood

41041

132863

2.23

307.65

7.4

5.1

1.91

1.97

e9/l

7.00

37100

117476

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

5578

12371

2.36

307.65

4.1

3.1

1.63

1.58

mmol/l

0.32

4115

8937

(3018677) aPTT in Platelet poor plasma by Coagulation assay

14079

31409

2.54

307.65

2.5

1.9

29.77

29.76

0.06

13657

30452

(3018418) pH of Serum or Plasma

23977

65650

2.23

307.65

5.0

3.4

7.40

0.16

4916

11968

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

8378

21100

2.12

307.65

3.1

2.2

38.52

47.89

u/l

1.01

7259

17997

(3015736) pH of Urine

29704

106405

1.67

307.65

3.8

2.8

5.90

5.88

0.83

2187

9648

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2873

5984

2.46

307.65

1.9

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2730

5251

2.67

307.65

3.4

3.1

43.97

43.16

mg/l

0.05

2197

4258

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1327

1673

4.03

307.65

1.7

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

26430

63940

2.67

307.65

2.5

1.8

206.47

217.71

u/l

0.62

25117

59481

(3041096) Erythrocytes [Presence] in Urine by Automated

19885

73855

1.48

307.65

3.8

2.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

41222

124969

2.47

307.65

7.9

4.9

10.83

11.56

umol/l

20.86

39364

117722

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5956

12298

2.55

307.65

7.7

7.1

24.76

24.70

mmol/l

0.51

5909

12190

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3087

6776

2.34

307.65

3.2

2.4

3.56

3.62

g/l

1.17

2944

6451

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

39138

114249

2.52

307.65

8.4

5.4

1.21

1.22

mmol/l

32.65

33687

96347

(3016502) Oxygen saturation in Arterial blood

8740

20708

2.26

307.65

8.3

7.5

95.57

95.87

3.32

8426

19905

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

35647

102964

2.42

307.65

7.5

5.0

1.21

mmol/l

38.22

33304

92987

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

10644

22013

2.66

307.65

5.0

3.6

242.90

240.29

u/l

0.61

10125

20747

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3831

5801

3.43

307.65

2.4

2.3

489.42

634.96

ug/l

0.91

3571

5379

(3022948) Iron [Moles/volume] in Serum or Plasma

13714

34604

2.21

307.65

2.9

2.2

13.07

14.58

umol/l

1.97

12840

32243

(3004789) Transferrin [Mass/volume] in Serum or Plasma

12831

31393

2.27

307.65

2.9

2.2

2.32

2.40

g/l

36.60

11952

28889

(3019069) Monocytes/100 leukocytes in Blood

37772

121176

2.15

307.65

7.8

5.5

8.53

8.41

10.32

35888

113198

(3019550) Sodium [Moles/volume] in Serum or Plasma

66420

288575

2.50

307.65

22.3

11.1

139.38

139.77

mmol/l

266.29

65393

279898

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

13991

40113

1.92

307.65

3.3

2.7

2.45

2.44

mmol/l

3.41

12329

34785

(3030467) Casts [#/volume] in Urine by Automated count

22786

63944

2.13

307.65

3.7

2.6

0.39

e6/l

0.06

18060

46656

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

6133

15471

2.07

307.65

4.6

3.6

96.82

85.01

ng/l

11.33

5370

13412

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2945

5659

2.67

307.65

1.4

273.12

282.82

ug/g

1.29

1682

3217

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

5876

11036

2.81

307.65

1.6

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

8230

17160

2.58

307.65

7.4

7.0

1.39

1.33

mmol/l

4.19

8032

16702

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

10899

19717

3.07

307.65

1.9

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

36274

133232

1.71

307.65

4.3

3.0

0.00

estimate

0.05

7477

23216

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

54815

201703

2.39

307.65

10.0

5.9

79.24

76.30

u/l

32.94

52524

189047

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

10882

19995

3.02

307.65

1.9

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

16843

51543

1.82

307.65

1.6

1.4

2.38

2.33

g/l

2.04

10903

31399

(3005719) IgG [Mass/volume] in Serum or Plasma

7964

15882

2.69

307.65

2.9

2.4

10.40

10.75

g/l

7.72

7383

14442

(3026008) Bacteria identified in Urine by Culture

23781

69475

2.05

307.65

3.4

2.5

—

(3006504) Eosinophils/100 leukocytes in Blood

37578

120426

2.14

307.65

7.5

5.2

2.76

2.91

27.10

35646

112283

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

46802

194048

1.57

307.65

3.9

2.6

53.53

42.71

u/l

86.79

44210

182404

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

67117

310414

1.90

307.65

13.8

8.1

27.41

26.76

u/l

6.67

65500

299152

(3003181) Sodium [Moles/volume] in Urine

1703

2619

3.31

307.65

1.5

1.4

61.99

65.89

mmol/l

2.33

1356

2041

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2941

3802

3.99

307.65

1.5

1.4

1454.35

2449.53

e6/l

0.46

2423

3037

(3001122) Ferritin [Mass/volume] in Serum or Plasma

33854

119599

1.77

307.65

3.4

2.6

134.62

105.91

ug/l

43.53

31691

111589

(3000494) Fungus identified in Specimen by Culture

9335

28819

1.71

307.65

1.6

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

4293

8448

2.64

307.65

3.7

2.5

0.66

0.65

0.28

4271

8420

(3020630) Protein [Mass/volume] in Serum or Plasma

7293

14950

2.60

307.65

2.6

2.3

66.23

67.16

g/l

16.40

6736

13535

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3087

5928

2.68

307.65

3.6

3.0

0.34

0.35

u/ml

0.47

1788

3250

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7999

23109

1.82

307.65

4.0

2.7

—

(3033658) Prothrombin time (PT) actual/Normal

20790

61195

1.98

307.65

5.1

3.2

90.73

92.08

10.48

20233

59564

(3021447) Carbon dioxide [Partial pressure] in Venous blood

8825

17710

2.70

307.65

5.0

3.2

5.86

5.81

kpa

3.75

8553

17160

(3011397) Hemoglobin [Presence] in Urine by Test strip

17386

59535

1.60

307.65

4.1

3.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

30076

84890

2.31

307.65

4.2

2.7

47.12

66.91

ng/l

1.22

20016

51110

(3019150) Specific gravity of Urine by Refractometry

16336

57437

1.55

307.65

4.6

3.3

1.02

kg/l

0.47

2347

8896

(40761535) Cells panel - Urine sediment

6390

18573

1.79

307.65

4.0

3.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

4441

8808

2.62

307.65

2.2

1.8

39.65

39.40

u/l

0.30

4008

7856

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1650

2434

3.45

307.65

1.5

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2698

4194

3.31

307.65

1.5

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1366

1363

5.10

307.65

1.4

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1100

1238

4.50

307.65

1.3

1.2

2.00

2.07

mmol/l

0.69

1029

1153

(3002030) Lymphocytes/100 leukocytes in Blood

38501

126132

2.10

307.65

7.6

5.3

27.70

28.98

84.75

36632

118266

(3013290) Carbon dioxide [Partial pressure] in Blood

2456

4225

2.98

307.65

4.3

3.6

5.02

5.00

kpa

0.52

2406

4121

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12999

42152

1.66

307.65

1.3

1.2

10.59

11.36

u/ml

0.39

5114

16926

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2750

4292

3.29

307.65

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

8202

17499

2.52

307.65

9.7

6.3

9.34

9.28

mmol/l

0.24

7881

16583

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5372

12739

2.20

307.65

9.7

9.1

1.45

1.36

6.92

5333

12664

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

66691

287454

2.65

307.65

20.7

9.6

22.68

23.04

mg/l

1.88

57040

216481

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1952

2842

3.51

307.65

1.5

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

12065

28906

2.30

307.65

3.0

2.3

22.80

23.61

6.33

10432

24557

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

15720

29875

3.08

307.65

2.1

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

4050

8941

2.34

307.65

1.3

1.2

0.78

0.97

u/ml

0.44

360

746

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

14000

38808

2.00

307.65

3.2

2.4

1.34

1.06

e6/l

0.78

8176

21198

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4566

11501

2.05

307.65

10.6

9.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1534

2211

3.53

307.65

1.5

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

2131

3883

2.80

307.65

3.4

3.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

4025

8039

2.59

307.65

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6475

16701

2.03

307.65

3.2

2.6

199.85

181.94

ng/l

1.99

5857

15105

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2719

3379

4.15

307.65

6.3

5.3

3392.31

816.76

iu/ml

0.85

392

486

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

28903

98250

1.78

307.65

2.1

1.8

95.71

97.23

pmol/l

5.45

16082

50633

(3035350) Ketones [Presence] in Urine by Test strip

36064

131648

1.73

307.65

4.3

3.0

0.00

estimate

4.10

7952

24992

(40758558) Short blood count panel - Blood

20461

62566

1.88

307.65

8.8

5.6

—

(4035726) Immunohistochemistry procedure

6841

19828

1.80

307.65

1.5

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

67362

307861

2.07

307.65

22.6

11.4

77.65

75.08

umol/l

51.90

67341

307720

(3044640) Blood type and Crossmatch panel - Blood

24325

79773

1.79

307.65

2.9

2.0

—

(40761511) CBC panel - Blood by Automated count

66393

305982

1.85

307.65

18.4

9.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2189

2359

4.76

307.65

3.1

2.6

8574.35

783.35

u/ml

0.96

124

100

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13886

44758

1.68

307.65

1.3

1.2

31.75

35.37

iu/ml

0.55

4192

14633

(40768804) Tissue Pathology biopsy report

27330

110085

1.39

307.65

2.2

2.0

—

(3002032) Base excess in Venous blood by calculation

8808

17643

2.70

307.65

5.0

3.3

1.92

1.76

mmol/l

3.23

7519

14734

(3028271) Lactate [Moles/volume] in Capillary blood

1760

2742

3.27

307.65

2.0

1.6

1.74

mmol/l

0.05

1729

2671

(1616796) Gas panel - Central venous blood

2399

4180

2.94

307.65

3.8

3.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2564

5070

2.59

307.65

2.4

1.9

0.04

0.02

g/l

1.51

2346

4624

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3098

6343

2.51

307.65

2.4

2.0

10.19

10.22

g/l

0.10

2784

5619

(3025159) Blasts/100 leukocytes in Blood

6791

17484

2.04

307.65

4.7

3.8

0.37

0.24

0.62

2238

3844

(3013512) EKG study

20344

68045

1.69

307.65

4.2

3.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

9839

23122

2.31

307.65

7.8

7.2

5.06

5.10

kpa

3.79

9420

22027

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1214

1439

4.28

307.65

2.0

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

9526

22291

2.31

307.65

3.0

2.3

1.81

1.70

15.60

8558

19584

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5862

12935

2.38

307.65

4.1

3.2

5.14

kpa

0.08

5588

12185

(3027273) Bicarbonate [Moles/volume] in Venous blood

4282

9227

2.41

307.65

4.3

2.9

25.24

25.21

mmol/l

0.18

4154

8915

(3022313) Gas panel - Capillary blood

3996

9561

2.16

307.65

4.5

3.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2579

5253

2.51

307.65

2.3

1.9

37.35

38.65

g/l

17.05

2278

4557

(3022096) Basophils/100 leukocytes in Blood

36615

116014

2.15

307.65

7.5

5.3

0.66

0.69

16.17

34669

107732

(3017143) Hepatitis C virus Ab [Presence] in Serum

11469

33437

1.85

307.65

1.7

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4910

9053

2.84

307.65

5.4

3.6

24.17

24.01

mmol/l

2.61

4803

8836

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2822

5761

2.51

307.65

2.5

2.1

0.76

0.86

g/l

0.63

2467

4937

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1582

2035

3.96

307.65

1.6

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5376

12707

2.21

307.65

9.8

9.2

0.69

0.67

1.57

5340

12645

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

20864

57880

2.12

307.65

3.4

2.6

1399.75

1227.91

ng/l

4.57

17811

48488

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

56806

255591

1.49

307.65

6.0

5.0

39.63

39.02

mmol/mol

35.68

53160

238000

(3003458) Phosphate [Moles/volume] in Serum or Plasma

11996

26729

2.49

307.65

7.3

5.0

1.05

1.04

mmol/l

5.29

11337

24797

(3002179) Metamyelocytes/100 leukocytes in Blood

6982

17337

2.12

307.65

4.4

3.6

0.74

0.64

1.68

2675

4532

(3019309) Folate [Moles/volume] in Red Blood Cells

14238

39375

2.00

307.65

1.8

1.6

1187.63

1156.09

nmol/l

3.18

11202

29549

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1495

2169

3.50

307.65

7.0

5.7

11.43

11.10

mg/l

1.49

1366

1999

(3019060) Gas panel - Arterial blood

5674

13073

2.27

307.65

5.4

4.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18249

61756

1.64

307.65

1.3

1.50

1.81

u/ml

2.65

5038

17016

(3023520) Reticulocytes [#/volume] in Blood

7233

15888

2.42

307.65

3.0

2.3

70.95

69.38

e9/l

2.28

5515

11797

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1965

2593

3.87

307.65

1.8

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1352

1571

4.37

307.65

1.9

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

16335

40962

2.28

307.65

4.2

3.0

307.50

677.27

ng/l

15.11

11684

29797

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

46769

203153

1.42

307.65

3.5

3.1

—

(3021589) Normoblasts [#/volume] in Blood

32940

118302

1.71

307.65

12.1

7.6

0.00

e9/l

1.36

27357

96521

(3016018) Differential panel - Cerebral spinal fluid

1419

1922

3.75

307.65

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

17557

51013

1.95

307.65

1.6

1.4

19.74

20.65

nmol/l

11.57

15511

43684

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

3010

6211

2.49

307.65

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

8362

19972

2.24

307.65

2.6

2.2

0.21

0.22

g/l

17.10

7751

18660

(3022217) INR in Platelet poor plasma by Coagulation assay

36266

105166

2.43

307.65

14.7

11.9

1.21

1.23

inr

1.73

11515

29954

(3012544) pH of Venous blood

9072

18443

2.67

307.65

5.0

3.3

7.37

7.38

0.49

125

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1965

2594

3.87

307.65

1.8

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2795

3707

3.89

307.65

1.8

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

60398

262109

1.84

307.65

5.4

4.3

2.00

2.11

mu/l

0.66

56601

241450

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

2452

3912

3.21

307.65

1.5

1.4

113.02

108.71

u/ml

0.53

515

875

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4411

8630

2.66

307.65

3.7

2.5

1.38

1.27

6.64

4384

8589

(3009508) Creatinine [Moles/volume] in Urine

21157

79910

1.46

307.65

3.6

3.1

7.63

8.18

mmol/l

2.46

18218

68121

(3009466) Valproate [Moles/volume] in Serum or Plasma

1909

2556

3.81

307.65

5.4

5.1

367.29

373.38

umol/l

0.79

1693

2179

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2157

3926

2.80

307.65

1.6

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

5400

12739

2.21

307.65

9.8

9.3

93.76

94.10

3.19

5379

12695

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

20089

50770

2.35

307.65

2.1

1.6

1.13

1.14

mg/l

0.16

15222

38032

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2656

5083

2.68

307.65

3.3

3.1

3.31

2.83

ratio

0.22

239

403

(3037522) Nuclear Ab [Titer] in Serum

12816

33333

2.12

307.65

1.4

1.3

497.90

563.45

titre

3.01

2566

6509

(3036489) Thrombin time

3697

8662

2.20

307.65

2.5

1.9

21.48

21.30

0.76

3225

7418

(40767503) Oxygen content in Capillary blood by calculation

2211

3904

2.89

307.65

2.6

2.3

16.42

16.89

4.17

1109

2052

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2063

2495

4.23

307.65

1.9

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

10968

36438

1.60

307.65

2.1

1.7

1.55

1.37

79.52

9617

32698

(36304419) Bacteria [Presence] in Urine

22153

63197

2.08

307.65

3.6

2.6

—

(3026782) Osmolality of Urine

17118

44513

2.21

307.65

3.3

2.4

528.30

559.26

mosm/kgh2o

49.24

15031

37592

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4009

8246

2.52

307.65

2.3

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

4025

6208

3.38

307.65

2.2

1.8

2.00

2.45

ug/l

0.74

3592

5442

(3044290) Cell count panel - Cerebral spinal fluid

2719

3637

3.85

307.65

1.4

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3344

6744

2.55

307.65

2.4

2.0

3.69

3.74

g/l

0.63

3048

6067

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2893

4579

3.25

307.65

1.4

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

48310

172847

2.15

307.65

5.3

3.5

1388.79

1273.98

e6/l

0.16

692

2379

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2683

3613

3.82

307.65

1.8

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2851

5445

2.69

307.65

1.4

1.5

14.50

14.42

iu/ml

0.01

122

(3036481) Cortisol [Moles/volume] in Serum or Plasma

9867

18736

2.89

307.65

2.3

2.1

367.41

378.18

nmol/l

4.80

9157

17210

(3044889) 12 lead EKG panel

45714

186804

1.59

307.65

4.1

3.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2728

5263

2.66

307.65

3.4

3.1

73.36

66.56

mg/l

0.11

2195

4271

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2342

3572

3.36

307.65

1.4

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

5389

11745

2.40

307.65

4.2

2.9

128.66

131.43

g/l

12.50

5260

11480

(3027315) Oxygen [Partial pressure] in Blood

2472

4248

2.98

307.65

4.3

3.6

8.73

8.80

kpa

0.89

2422

4143

(3024354) Oxygen [Partial pressure] in Venous blood

7196

14476

2.65

307.65

4.3

2.7

4.72

4.66

kpa

1.01

6946

13976

(3000991) Gas panel - Venous blood

7855

16711

2.52

307.65

9.3

8.1

—

(3023368) Bacteria identified in Blood by Culture

24575

53918

2.92

307.65

5.3

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

6175

12337

2.64

307.65

1.9

1.7

1.27

1.32

g/l

0.82

5711

11239

(3023103) Potassium [Moles/volume] in Serum or Plasma

66484

289656

2.48

307.65

22.4

11.2

3.95

3.96

mmol/l

1.03

65347

280311

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

4003

8371

2.48

307.65

4.8

3.2

50.41

47.99

6.26

3964

8269

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

13110

36331

1.98

307.65

3.4

2.5

3.01

2.89

e6/l

0.46

7341

18808

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

27817

103138

1.56

307.65

4.4

3.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

34259

125348

1.69

307.65

3.0

2.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

3163

6736

2.41

307.65

4.4

4.0

1.38

1.39

mmol/l

0.20

3103

6632

(3027801) Oxygen [Partial pressure] in Arterial blood

9833

23109

2.30

307.65

7.8

7.2

12.36

12.80

kpa

10.35

9401

22016

(3018095) Leukocytes [#/volume] in Urine

28077

85830

2.03

307.65

4.4

3.1

83.43

96.10

e6/l

1.29

21180

56811

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

20459

57970

2.06

307.65

2.5

2.1

2.95

2.84

mg/l

6.96

17747

49225

(3023183) Ammonium ion [Moles/volume] in Plasma

2533

3352

3.88

307.65

3.2

2.5

34.27

34.49

umol/l

0.12

2319

3018

(3012095) Magnesium [Moles/volume] in Serum or Plasma

15029

33119

2.60

307.65

4.3

2.9

0.81

0.82

mmol/l

28.85

14211

30903

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1455

2014

3.67

307.65

1.5

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

18754

59704

1.77

307.65

2.8

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

59878

273808

1.50

307.65

4.7

4.0

5.93

5.84

mmol/l

44.21

55380

252142

(3017181) Myelocytes/100 leukocytes in Blood

7653

19009

2.13

307.65

4.7

3.8

0.96

0.90

0.86

3080

5251

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

7282

13633

2.86

307.65

1.8

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3542

6354

2.88

307.65

1.8

1.6

1.19

1.16

g/l

4.40

3372

6058

(3010421) pH of Blood

2761

4958

2.86

307.65

4.3

3.4

7.42

0.33

2515

4530

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3349

6766

2.55

307.65

2.4

2.0

7.39

7.29

g/l

2.03

3052

6076

(3003396) Base excess in Arterial blood by calculation

9819

23162

2.30

307.65

7.8

7.1

1.08

0.93

mmol/l

2.83

7810

18295

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

3510

6786

2.67

307.65

1.6

295.85

283.35

titre

0.08

135

258

(40760892) CBC W Ordered Manual Differential panel - Blood

38276

119606

2.25

307.65

8.0

5.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

2409

4633

2.66

307.65

3.8

3.1

8.45

8.47

kpa

0.14

2347

4528

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

26880

74057

2.29

307.65

3.2

2.2

62.45

62.31

u/l

0.01

25148

68013

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2935

3801

3.99

307.65

1.4

34.28

25.11

e6/l

0.65

2297

2893

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6690

17765

1.97

307.65

4.6

3.2

1.22

1.23

mmol/l

14.32

6017

15165

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2546

4742

2.75

307.65

3.3

2.8

24.54

24.69

mmol/l

0.84

2487

4634

(3013826) Glucose [Moles/volume] in Serum or Plasma

45556

144719

2.50

307.65

6.0

3.8

6.62

6.67

mmol/l

3.72

43318

132268

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26427

86075

1.84

307.65

4.0

2.8

34.40

32.53

u/l

1.54

25166

81636

(3013115) Eosinophils [#/volume] in Blood

41284

132822

2.26

307.65

7.6

5.3

0.19

e9/l

10.46

37055

116296

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

7111

16575

2.27

307.65

2.5

2.0

6.84

8.06

ug/l

3.48

6192

14504

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

5600

10248

2.88

307.65

1.8

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4443

8518

2.72

307.65

1.6

1.5

10.78

15.74

u/ml

1.33

129

253

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

15390

50359

1.67

307.65

1.7

1.6

32608467.31

38875558.87

pmol/l

0.58

13052

41996

(3037467) Urinalysis macro (dipstick) panel - Urine

49449

185273

2.02

307.65

5.2

3.6

—

(3029937) Albumin [Presence] in Urine by Test strip

20082

69657

1.61

307.65

4.7

3.3

0.00

estimate

0.76

7397

23020

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

3329

4322

3.99

307.65

1.4

1.2

540.49

534.83

mg/l

0.08

3185

4114

(3002173) Hemoglobin [Mass/volume] in Arterial blood

8035

19309

2.22

307.65

8.8

7.9

121.67

123.01

g/l

5.62

7834

18745

(3026493) Urate [Moles/volume] in Serum or Plasma

19386

65618

1.65

307.65

3.1

2.2

2800.38

4557.75

umol/l

9.56

17186

58155

(3028707) Methadone [Presence] in Urine by Screen method

2444

5040

2.48

307.03

3.9

2.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3475

8448

2.11

301.32

4.6

3.3

24.68

24.73

mmol/l

0.39

3240

7821

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4476

11968

1.93

300.60

3.1

2.4

0.30

0.27

e6/l

0.54

4356

11588

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5551

15933

1.81

300.39

3.2

3.4

4.46

4.58

pmol/l

10.76

4924

14305

(3024980) IgG subclass 4 [Mass/volume] in Serum

1880

3414

2.80

300.02

1.7

1.5

0.74

0.77

g/l

0.40

1427

2591

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1360

2022

3.41

297.70

1.1

45.95

82.50

au/ml

0.77

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3449

8410

2.11

296.71

5.9

4.5

1.75

1.69

1.87

3239

7844

(3005322) IgE [Units/volume] in Serum or Plasma

5747

16775

1.78

294.08

1.4

1.3

255.81

254.65

u/ml

0.02

5301

15542

(3021901) Oxygen saturation in Capillary blood

1852

3383

2.79

292.45

2.9

2.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

3386

8264

2.10

290.48

6.0

4.6

0.89

0.91

0.86

3187

7703

(3004809) Band form neutrophils/100 leukocytes in Blood

1699

2964

2.92

290.38

3.5

2.9

1.61

1.42

1.05

1549

2580

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

795

766

5.24

289.40

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1422

2237

3.23

286.49

1.9

1.6

90.10

90.26

0.40

1402

2202

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

15733

58724

1.43

283.68

1.7

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2911

6742

2.21

283.57

3.0

2.3

190.08

179.54

6.87

2764

6380

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1970

3820

2.63

278.85

1.2

167.00

120.77

titre

0.30

(40768795) Lymph node Pathology biopsy report

1144

1578

3.67

277.55

1.3

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2196

4517

2.48

276.97

1.5

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

69309

331366

1.76

275.61

29.9

14.8

40.09

40.88

7.93

65761

311160

(3037756) Immunofixation for Serum or Plasma

1827

3448

2.70

271.92

1.7

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1846

3530

2.66

268.13

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

3071

7465

2.11

265.66

1.6

7.50

5.78

iu/ml

0.11

664

1497

(3007461) Platelets [#/volume] in Blood

69314

331742

1.74

265.62

29.8

14.8

253.43

253.83

e9/l

0.81

68267

322158

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1981

3965

2.54

263.69

1.6

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

2752

6423

2.19

262.91

3.4

2.7

—

(3047181) Lactate [Moles/volume] in Blood

2853

6792

2.15

259.79

6.5

5.2

1.36

1.28

mmol/l

2.91

2541

5963

(3035941) MCH [Entitic mass]

69336

332081

1.73

259.77

29.6

14.7

30.24

30.21

4.30

68760

327096

(3035637) Corticotropin [Mass/volume] in Plasma

1439

2432

3.00

259.01

1.6

1.5

—

(3010813) Leukocytes [#/volume] in Blood

69350

332207

1.73

258.62

29.8

14.8

6.90

6.65

e9/l

63.73

68169

321640

(3024731) MCV [Entitic volume]

69337

332130

1.73

258.54

29.6

14.7

90.79

90.50

49.44

68761

327127

(3026361) Erythrocytes [#/volume] in Blood

69341

332171

1.73

258.07

29.7

14.8

4.46

4.56

e12/l

307.65

68156

321651

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1148

1677

3.47

257.51

1.7

1.3

1.34

1.50

promille

2.17

845

1334

(3000963) Hemoglobin [Mass/volume] in Blood

69356

332309

1.73

256.76

29.9

14.9

133.93

137.19

g/l

307.65

68777

327347

(3024928) Oxygen saturation in Venous blood

1986

4036

2.51

256.45

4.2

3.0

—

(3045142) Bone marrow Pathology biopsy report

1134

1663

3.45

252.98

1.4

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1215

1870

3.29

252.80

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

2772

6604

2.15

251.83

1.3

1.2

104.25

122.98

titre

0.59

266

601

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2621

6106

2.19

251.32

4.7

3.0

1.55

1.38

mg/l

15.68

2456

5607

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

950

1225

3.92

251.30

2.3

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

19269

75776

1.37

251.22

4.1

3.8

13.13

7.54

mg/mmol

26.71

12711

47775

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1513

2696

2.85

249.23

1.8

1.5

—

(3012516) Albumin [Mass/volume] in Urine

18419

72043

1.37

247.53

3.5

3.2

548.99

338.46

mg/l

5.96

12392

45452

(1175426) CD3 cells/100 lymphocytes in Blood

1001

1367

3.70

246.03

2.3

1.9

73.73

72.24

1.75

958

1319

(3034770) Mitochondria Ab [Titer] in Serum

2710

6482

2.14

243.68

1.3

1.2

936.94

1001.11

titre

0.17

190

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

985

1346

3.70

241.89

2.3

1.8

14.01

15.17

2.29

954

1313

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2684

6426

2.13

240.72

1.3

1.2

41.22

35.80

u/ml

0.41

165

378

(3022145) Colonoscopy Study observation

8442

28610

1.54

240.27

1.4

1.3

—

(40761536) Microorganisms panel - Urine sediment

6868

22211

1.61

238.59

4.6

3.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

6167

19438

1.64

237.15

3.0

2.3

67.80

70.11

ml/min/173m2

3.20

2567

7086

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1620

3089

2.66

236.35

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1196

1945

3.11

228.80

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

750

863

4.39

227.02

2.5

1115.52

780.01

u/ml

1.93

742

856

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

916

1257

3.68

223.69

2.7

2.4

537.77

509.82

e6/l

0.71

763

1046

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2476

5939

2.13

220.77

1.3

1.2

8.73

8.67

u/ml

0.01

377

911

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2442

5840

2.13

219.33

1.3

1.2

6.95

6.14

u/ml

0.15

250

598

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

865

1155

3.78

218.91

1.6

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

724

834

4.38

218.89

1.5

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

892

1220

3.69

218.78

2.8

2.4

0.22

0.24

e9/l

1.75

767

1038

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1476

2796

2.68

217.88

1.3

0.26

0.24

nmol/l

0.11

161

(4062490) Immunoglobulin typing, IgG

1229

2104

2.96

216.46

1.5

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4405

12971

1.75

216.18

2.5

2.2

6362.45

5997.63

u/l

0.27

1587

5405

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1475

2808

2.66

215.73

1.3

1.34

1.25

nmol/l

0.04

1429

2706

(3003327) Ova and parasites identified in Stool by Light microscopy

3278

8801

1.91

215.57

1.8

1.7

—

(3037121) Protein [Mass/volume] in Urine

2936

7605

1.97

213.87

3.5

3.1

0.37

0.30

g/l

1.87

1458

3248

(21494815) CD4 cells/100 lymphocytes in Specimen

1059

1668

3.21

212.78

2.4

2.0

38.60

39.51

0.91

1033

1641

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2583

6403

2.06

211.71

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

1076

1719

3.17

211.56

1.5

279.99

281.66

mosm/kgh2o

1.12

830

1363

(3027135) IgG subclass 1 [Mass/volume] in Serum

1219

2112

2.92

210.46

1.5

1.3

6.75

g/l

0.01

861

1449

(3028192) IgG subclass 2 [Mass/volume] in Serum

1219

2113

2.92

210.29

1.5

1.3

2.84

3.08

g/l

3.69

862

1450

(3024139) IgG subclass 3 [Mass/volume] in Serum

1218

2112

2.92

210.00

1.5

1.3

0.38

0.42

g/l

1.66

859

1456

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

809

1059

3.86

209.99

1.7

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

710

835

4.29

209.67

1.3

66.12

66.66

0.04

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2022

4610

2.23

203.44

1.3

1.2

10.97

19.32

u/ml

0.61

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1787

3856

2.35

203.35

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1062

1742

3.08

200.39

1.2

1.1

39.21

44.64

mg/l

1.79

896

1461

(3016650) Hepatitis A virus Ab [Presence] in Serum

1801

3958

2.31

196.87

1.1

—

(36660697) Celiac disease serology panel - Serum

6576

21993

1.55

195.80

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

3251

8985

1.85

195.54

4.1

2.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2024

4696

2.19

195.37

1.3

1.2

4.05

6.16

u/ml

0.57

145

361

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2055

4825

2.17

192.77

1.5

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

653

770

4.28

192.27

2.3

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

653

770

4.28

192.27

2.3

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1024

1685

3.07

192.24

1.1

255.89

264.16

mg/l

0.28

900

1490

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

825

1178

3.54

190.96

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

810

1146

3.57

189.86

3.2

1.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

1595

3375

2.40

189.16

4.2

2.7

64.12

66.37

3.13

1589

3362

(3010503) CD19 cells [#/volume] in Blood

754

1017

3.74

188.35

2.8

2.4

0.30

0.33

e9/l

0.09

733

992

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

894

1367

3.30

187.74

2.7

2.4

681.64

708.65

e6/l

0.65

860

1334

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1313

2533

2.63

187.23

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1302

2505

2.63

186.61

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1049

1791

2.96

185.53

3.4

2.8

57.50

55.29

2.09

909

1478

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

2042

4866

2.13

184.67

1.3

1.2

38.74

45.26

u/ml

0.83

207

441

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1368

2721

2.55

183.94

2.4

2.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

474

431

5.54

182.27

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

987

1646

3.03

181.38

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2581

6773

1.94

180.76

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2043

4919

2.11

180.03

2.3

2.0

129.83

132.72

g/l

4.67

1555

3535

(3026250) Tacrolimus [Mass/volume] in Blood

644

797

4.07

179.17

36.8

34.2

7.47

7.35

ug/l

0.56

585

730

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2764

7472

1.89

177.46

3.7

3.4

1791.86

1969.01

u/ml

0.05

2386

6430

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

835

1267

3.33

177.34

1.8

3.84

3.56

mg/l

0.79

788

1205

(1001926) Buprenorphine [Presence] in Urine by Screen method

3584

10572

1.73

173.71

3.2

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1108

2033

2.76

173.19

4.1

3.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1323

2672

2.51

172.57

1.6

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

849

1331

3.22

171.79

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

615

763

4.06

170.61

29.2

25.0

118.06

121.82

ug/l

0.43

507

629

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1295

2603

2.52

170.52

1.6

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

3103

8830

1.79

169.63

1.5

1.4

9.81

9.15

u/l

1.72

2518

7211

(3014765) Yersinia sp identified in Stool by Organism specific culture

2630

7111

1.88

168.63

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1280

2573

2.52

168.52

1.6

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

2634

7135

1.88

167.95

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1292

2616

2.50

167.66

1.6

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1280

2580

2.51

167.61

1.6

1.3

—

(3017732) Neutrophils [#/volume] in Blood

5489

18226

1.55

167.33

2.9

2.6

4.74

4.87

e9/l

0.33

4492

15085

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

558

648

4.34

167.24

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1278

2578

2.51

167.08

1.6

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

843

1348

3.16

165.51

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2600

7051

1.88

165.17

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

619

810

3.85

160.80

2.4

1.8

116.98

154.31

umol/l

1.64

314

409

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8377

30568

1.42

159.81

8.6

5.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5766

19569

1.52

158.82

1.2

121.49

151.40

iu/ml

6.61

2108

7564

(3023511) Choriogonadotropin [Units/volume] in Urine

2350

6259

1.91

157.39

1.4

1.3

—

(3042631) Mycobacterium sp identified in Specimen

1226

2501

2.48

156.70

2.6

2.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2687

7503

1.82

155.85

1.4

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

662

938

3.56

154.91

1.5

1.3

—

(3000012) Reticulocyte production index

1228

2544

2.44

152.09

2.3

2.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

613

842

3.67

149.58

1.2

1.1

3.74

4.10

iu/ml

0.25

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

511

607

4.24

149.28

2.5

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3081

9092

1.73

148.60

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

504

594

4.27

148.57

2.5

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

504

595

4.27

148.29

2.5

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3824

11973

1.63

148.15

2.4

2.3

—

(3023419) Bacteria identified in Sputum by Culture

1305

2822

2.34

147.60

2.6

2.4

—

(3045414) Leukocytes [Presence] in Urine

3560

10961

1.66

147.10

2.0

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

695

1060

3.31

146.54

2.9

2.6

39.35

40.58

0.69

400

536

(3039000) Anion gap in Blood

1890

4787

2.00

145.71

8.0

6.1

11.29

11.25

mmol/l

0.15

1713

4283

(3018572) Chloride [Moles/volume] in Blood

1890

4788

2.00

145.63

8.0

6.1

104.97

105.35

mmol/l

2.47

1714

4284

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

599

827

3.65

145.18

1.6

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

602

837

3.62

144.55

1.6

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1434

3267

2.22

144.22

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10120

38752

1.36

143.52

2.2

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1544

3636

2.15

143.50

1.1

—

(3016879) Cocaine [Presence] in Urine

4062

13015

1.60

143.31

3.1

1.8

—

(3016038) Potassium [Moles/volume] in Urine

663

995

3.36

143.13

1.3

33.75

35.83

mmol/l

1.11

568

876

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

467

535

4.39

142.19

1.9

1.5

25165.18

18950.59

u/ml

0.12

(3000764) Benzodiazepines [Presence] in Urine

4303

14016

1.57

141.64

3.1

1.8

—

(4200892) Spirometry reversibility

5293

18072

1.50

140.94

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1636

3973

2.09

140.83

1.9

5.06

5.39

mmol/24h

2.97

1477

3547

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

720

1158

3.14

140.14

1.1

1.09

1.03

u/l

0.63

326

516

(3020961) Endomysium IgA Ab [Titer] in Serum

4113

13305

1.58

139.33

1.1

147.58

219.85

titre

1.15

414

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

676

1051

3.24

138.56

1.6

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3620

11372

1.63

138.17

1.7

1.6

314.69

304.27

mu/l

0.66

3259

10252

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

929

1755

2.67

137.73

1.3

1.2

200.19

182.59

titre

0.22

159

286

(3028300) Cannabinoids [Presence] in Urine

4319

14182

1.56

137.17

3.1

1.8

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

926

1753

2.67

136.76

1.3

1.2

194.00

174.93

titre

0.09

(3027008) Opiates [Presence] in Urine

4299

14156

1.55

134.80

3.0

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

739

1239

3.01

134.69

1.7

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

474

579

4.12

134.06

2.8

2.9

28.67

28.39

umol/l

0.15

354

452

(3008898) HLA-B27 [Presence]

3210

9852

1.66

133.96

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10994

43031

1.33

133.82

2.3

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

660

1037

3.21

133.16

1.6

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

688

1116

3.11

132.17

1.5

1.4

5.76

5.82

u/l

0.05

596

933

(3006245) CD3-CD19+ cells/100 cells in Blood

536

733

3.68

131.61

2.4

2.0

10.51

10.73

0.12

496

690

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3440

10814

1.62

130.76

1.1

7.81

11.07

u/ml

0.20

159

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

502

656

3.85

130.72

1.3

1.2

0.30

g/l

0.13

406

512

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2838

8508

1.70

129.09

1.9

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1624

4070

2.02

128.72

3.6

3.2

679.68

942.69

u/ml

0.44

1486

3679

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

520

707

3.70

128.67

2.3

1.9

30.42

27.59

3.41

488

675

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

904

1749

2.61

128.18

3.3

2.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

60876

290339

1.28

126.68

4.9

4.4

2.73

2.83

mmol/l

129.41

56732

270874

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5981

21354

1.44

126.53

2.4

2.1

11.93

12.62

nmol/l

7.93

5347

19443

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

954

1914

2.52

126.07

2.0

2.2

19.84

19.24

nmol/l

0.88

891

1839

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1540

3815

2.04

125.86

1.3

1.2

3.90

3.73

u/ml

0.23

699

1704

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

674

1117

3.04

125.18

1.1

2.28

7.89

nmol/l

2.20

123

216

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

356

357

5.01

124.83

1.8

2.0

47.08

31.38

u/l

0.69

323

314

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1621

4111

2.00

124.42

3.6

2.9

—

(3042733) HLA Ab [Presence] in Serum

488

649

3.78

124.29

4.6

5.2

—

(3027944) Amphetamines [Presence] in Urine

4195

13991

1.53

123.93

2.9

1.7

—

(3022621) pH of Urine by Test strip

4816

16549

1.49

123.68

3.2

2.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1069

2290

2.36

123.38

3.2

3.4

7.55

7.54

nmol/l

0.00

1032

2226

(3011985) Renin [Units/volume] in Plasma

1298

3034

2.16

122.79

1.6

65.90

67.65

mu/l

0.08

1143

2754

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

943

1907

2.50

122.66

1.1

—

(3003694) ABO and Rh group [Type] in Blood

19775

84154

1.24

122.30

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

463

599

3.89

122.13

1.3

1.1

109.62

111.91

0.79

421

530

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

535

773

3.48

121.96

1.6

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

535

774

3.48

121.74

1.6

1.2

—

(3024471) HLA-A [Type]

479

645

3.74

120.07

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

57683

273764

1.25

119.84

4.1

3.6

1.34

1.28

mmol/l

63.02

53507

254176

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

358

377

4.77

119.46

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1095

2410

2.30

119.11

2.2

2.0

32.67

32.78

0.30

1088

2386

(3016228) CD19 cells/100 cells in Blood

492

682

3.63

118.70

2.3

1.8

8.23

9.22

0.75

480

666

(21494890) Protein electrophoresis panel - 24 hour Urine

906

1827

2.50

118.53

2.1

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

361

387

4.69

118.24

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1559

3977

1.98

117.73

1.3

1.2

4.27

3.24

u/ml

0.93

540

1346

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

359

387

4.66

116.90

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1232

2878

2.16

116.71

1.3

1.2

49.84

53.80

u/ml

0.18

185

(3000093) Morphology [Interpretation] in Blood Narrative

920

1884

2.46

116.69

1.2

1.1

—

(3024932) HLA-DR beta [Type]

467

631

3.72

116.55

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1300

3108

2.11

116.34

3.0

2.8

269.89

864.62

u/ml

0.89

1285

3071

(21494814) CD8 cells/100 lymphocytes in Specimen

481

669

3.62

115.54

2.3

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

816

1583

2.60

115.14

20.0

18.5

2594.92

2359.83

nmol/l

0.06

782

1521

(3013139) Helicobacter pylori Ag [Presence] in Stool

5012

17602

1.46

115.09

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2006

5615

1.81

115.05

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

1674

4417

1.92

114.92

3.9

2.4

1.54

1.59

mmol/l

1.24

1640

4328

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

417

521

4.03

114.86

1.2

1.3

23.56

18.45

0.55

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

260

203

6.43

114.12

1.5

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

781

1494

2.64

113.17

14.5

13.1

820.07

1487.38

nmol/l

0.50

748

1447

(3000475) Leukocytes [#/volume] in Synovial fluid

1921

5332

1.83

113.15

1.7

1.6

13932.36

13085.65

e6/l

0.28

1410

3862

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

357

396

4.53

112.75

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

59912

286173

1.26

111.20

4.5

4.0

4.60

4.73

mmol/l

180.11

56089

268440

(40765096) Chromosome analysis panel by Banding

337

360

4.71

110.83

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

492

719

3.44

110.44

1.1

454.35

642.37

ng/l

0.26

104

171

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2074

5946

1.77

109.96

1.5

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

569

923

3.10

109.39

2.2

35.55

39.97

umol/l

0.16

(3004616) Nuclear Ab [Presence] in Serum

1163

2726

2.16

109.28

1.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

693

1266

2.76

109.25

3.0

3.6

138.47

126.79

nmol/l

0.26

679

1246

(3002256) Pathology report gross observation

8862

34521

1.32

109.25

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1187

2821

2.13

107.81

1.3

1.4

516.72

334.48

pmol/l

0.85

1019

2476

(3029634) Reagin Ab [Titer] in Serum by VDRL

1491

3863

1.95

107.81

2.1

6.57

7.52

titre

0.09

116

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

702

1304

2.71

107.41

2.6

1.8

95.62

98.98

1.41

663

1197

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

352

405

4.37

106.80

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1058

2409

2.22

106.52

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3028

9701

1.59

106.10

1.6

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

404

526

3.86

105.80

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1308

3260

2.03

105.16

1.1

1.52

1.47

g/l

3.73

1189

2943

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

333

372

4.50

104.41

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1443

3738

1.95

104.38

1.1

118.54

117.61

0.44

1315

3374

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1073

2481

2.18

104.19

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

1051

2415

2.20

103.58

8.1

7.8

7.52

7.28

mmol/l

0.56

892

1921

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

987

2208

2.26

103.51

1.2

62.22

65.61

u/l

0.48

890

1973

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

391

506

3.89

103.19

2.3

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2113

6208

1.73

102.97

1.2

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

845

1768

2.41

102.56

2.6

2.5

0.43

0.60

—

(3000330) Specific gravity of Urine by Test strip

3504

11706

1.52

102.18

4.0

2.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

59416

284163

1.24

102.02

4.5

3.9

1.42

1.47

mmol/l

135.33

55407

265528

(3006922) Hepatitis E virus Ab [Presence] in Serum

795

1634

2.45

100.13

1.1

—

(3044927) Protein electrophoresis panel - Urine

812

1689

2.42

99.78

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1389

3607

1.95

99.77

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

983

2231

2.22

99.74

2.6

2.5

1.34

g/24h

0.02

525

1109

(3000060) B lymphocytes [#/volume] in Blood

403

552

3.67

98.88

2.3

1.9

284.68

1108.44

e6/l

0.94

222

294

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

309

340

4.57

98.53

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

737

1475

2.52

97.94

12.7

11.6

0.61

0.62

mmol/l

0.21

687

1349

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

769

1575

2.46

97.56

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1053

2492

2.13

96.66

1.3

1.2

27.00

30.11

nmol/l

0.18

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

763

1566

2.46

96.39

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

739

1493

2.49

96.39

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

742

1503

2.49

96.27

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

528

890

2.99

95.54

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1145

2814

2.05

95.52

1.2

1.1

1.97

1.77

iu/ml

0.13

(3051651) Icteric interference index of Serum or Plasma

626

1165

2.71

95.51

4.2

3.6

—

(3041354) Potassium [Moles/volume] in Venous blood

1002

2345

2.16

94.53

2.8

1.9

4.05

4.04

mmol/l

0.08

994

2325

(3035285) Chloride [Moles/volume] in Venous blood

1002

2345

2.16

94.53

2.8

1.9

105.65

105.61

mmol/l

0.08

994

2325

(3004716) Salmonella sp identified in Stool by Organism specific culture

4278

15136

1.44

93.79

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

1535

4212

1.84

93.64

4.1

2.5

7.40

7.64

mmol/l

2.13

1505

4141

(3003434) Protein [Mass/volume] in Pleural fluid

1016

2404

2.13

93.31

1.5

1.4

32.11

34.21

g/l

4.71

920

2168

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

586

1066

2.77

93.16

1.7

1.5

2416572.89

1585103.95

iu/ml

0.59

(21494434) Karyotype in Bone marrow

742

1532

2.44

92.62

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

2557

8124

1.60

92.54

2.5

2.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4213

14906

1.44

92.32

1.4

1.3

25.25

26.69

iu/l

1.91

3543

12885

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

464

738

3.16

92.06

3.1

2.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

983

2308

2.15

92.02

2.8

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1454

3954

1.86

91.19

1.1

—

(3021788) Differential panel - Synovial fluid

1489

4087

1.84

90.75

1.6

1.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

317

387

4.12

89.90

1.2

271.11

700.80

titre

0.51

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

799

1733

2.32

89.84

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

798

1731

2.32

89.71

1.2

1.1

—

(3003338) MCHC [Mass/volume]

54317

258333

1.20

89.69

25.5

12.7

332.59

333.10

g/l

29.63

53921

256207

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

813

1779

2.30

89.66

1.2

1.1

56.69

61.70

u/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

799

1735

2.32

89.62

1.2

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

517

896

2.90

89.38

1.9

1.8

1.93

1.97

umol/l

0.59

483

838

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

805

1757

2.31

89.28

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

483

804

3.02

89.23

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

483

804

3.02

89.23

1.5

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

803

1753

2.31

89.02

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

732

1531

2.41

88.98

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

306

366

4.20

88.91

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

1060

2601

2.06

88.81

2.4

2.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

803

1755

2.31

88.79

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1249

3262

1.93

88.28

1.8

2355.00

4103.29

titre

0.85

158

(3028433) Virus identified in Specimen by Culture

400

594

3.39

87.89

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

491

835

2.96

87.61

3.6

3.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1049

2578

2.05

87.53

1.7

1.5

31.03

34.49

iu/ml

0.28

(40768443) Skin Pathology biopsy report

3231

10967

1.50

87.16

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1400

3830

1.85

86.20

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

381

556

3.45

85.82

3.4

3.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

643

1290

2.51

85.11

1.5

1.4

12.77

12.33

u/l

0.70

615

1253

(3019420) Tryptase [Mass/volume] in Serum or Plasma

611

1202

2.56

84.05

1.5

7.73

7.77

ug/l

0.02

547

1090

(21491868) Cryoglobulin [Mass/volume] in Serum

415

652

3.20

83.95

1.2

0.24

0.46

g/l

0.56

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

432

697

3.12

83.89

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

209

182

5.77

83.82

1.6

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1547

4405

1.78

83.80

1.4

1.3

25.74

24.46

u/l

0.74

1280

3619

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6364

24513

1.33

83.16

2.1

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

913

2168

2.12

83.16

1.5

1.4

3601.50

2975.20

e6/l

0.29

669

1559

(3042517) Benzodiazepines panel - Urine

240

245

4.92

82.85

3.3

2.6

—

(3019977) pH of Arterial blood

553

1046

2.66

81.98

2.5

7.42

0.02

163

388

(21494755) Public health laboratory ask at order entry panel

5728

37175

0.75

81.80

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1231

3284

1.89

81.80

3.1

2.9

0.83

0.79

nmol/l

1.76

894

2527

(3000492) Spirometry study

7217

28357

1.30

81.78

1.5

1.4

—

(3044941) Cell count panel - Synovial fluid

1263

3407

1.87

81.18

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

795

1802

2.22

80.98

3.8

4.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

976

2408

2.04

80.64

2.0

1.9

24.06

25.91

ug/l

0.35

953

2362

(3008536) Aspergillus sp Ab [Presence] in Serum

256

286

4.50

80.40

2.5

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

497

896

2.79

80.35

1.1

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

562

1088

2.60

79.77

1.6

1.5

23.51

25.24

umol/l

0.58

535

1034

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

262

302

4.36

79.48

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

480

854

2.83

79.42

1.1

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

578

1143

2.55

78.75

1.4

1.2

279.92

359.71

u/l

0.82

537

1073

(3047007) Chlamydophila sp Ab [Presence] in Serum

1382

3880

1.80

78.40

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4208

15339

1.40

77.71

1.1

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

746

1677

2.24

77.47

1.2

47.02

46.96

u/ml

0.00

112

(3038026) Centromere Ab [Units/volume] in Serum

759

1721

2.22

77.27

1.2

53.37

45.27

u/ml

0.23

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

722

1602

2.27

77.25

1.2

8.36

10.81

u/ml

0.21

106

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

744

1674

2.24

77.11

1.2

73.58

59.28

u/ml

0.55

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

191

166

5.78

76.78

3.2

42.12

41.40

umol/l

0.12

167

138

(3045716) Anion gap in Serum or Plasma

453

795

2.87

76.76

2.7

2.3

9.71

10.12

mmol/l

1.21

440

772

(40768446) Kidney Pathology biopsy report

469

841

2.80

76.57

1.8

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1292

3596

1.81

75.37

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16358

71035

1.20

74.74

1.7

1.6

1.46

1.36

mmol/l

26.28

13940

60310

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1055

2757

1.93

74.47

1.1

95.96

96.28

0.13

995

2576

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5137

19486

1.34

74.00

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

172

140

6.17

73.15

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1279

3589

1.80

72.69

1.7

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1440

4198

1.73

72.01

1.1

14.38

11.27

au/ml

0.57

300

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

773

1822

2.14

71.77

1.1

288.72

452.12

mg/l

0.50

706

1629

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3757

13615

1.40

71.61

3.7

3.0

61.77

43.58

u/ml

1.33

3624

13166

(40768441) Liver Pathology biopsy report

714

1631

2.20

71.48

1.6

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2020

6453

1.58

71.31

1.8

1.9

12.80

20.78

iu/l

0.33

727

2469

(3014051) Protein [Presence] in Urine by Test strip

1974

6276

1.59

71.09

2.6

2.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

451

826

2.75

70.98

2.6

2.3

142.77

155.25

nmol/l

1.32

391

718

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

827

2012

2.07

70.91

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

785

1871

2.11

70.91

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

659

1463

2.27

70.47

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

1410

4114

1.73

70.31

1.6

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

894

2251

2.00

70.02

3.8

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

811

1972

2.07

69.65

1.5

1.4

52139.29

48983.29

e6/l

0.10

495

1164

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1217

3408

1.80

69.64

1.3

1.2

40.48

28.37

u/l

1.84

1078

2945

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

721

1688

2.15

68.08

1.4

12.35

11.56

umol/l

2.13

679

1600

(40768806) Pleura Pathology biopsy report

780

1885

2.08

68.06

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

458

868

2.65

67.76

2.0

1.7

27.83

29.36

umol/l

2.12

443

837

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

248

313

3.98

67.72

5.8

5.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

706

1645

2.16

67.45

3.2

3.3

25.54

28.91

mu/l

1.33

662

1547

(3001964) Herpes simplex virus Ag [Presence] in Specimen

356

587

3.05

66.93

1.6

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

577

1236

2.35

66.80

1.3

1.2

101.66

78.90

u/l

3.77

506

1082

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

536

1112

2.42

66.41

1.6

1.8

149.93

134.17

3.76

503

1049

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

188

192

4.91

65.00

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

698

1644

2.14

64.98

1.3

410.23

529.56

u/l

1.05

657

1565

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

560

1199

2.35

64.92

1.3

1.2

26.91

18.66

u/l

2.95

485

1028

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

583

1272

2.31

64.86

1.6

1.5

6.89

6.51

u/l

0.22

454

1028

(3044242) Glucose [Moles/volume] in Arterial blood

442

851

2.61

63.52

2.1

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

680

1601

2.14

63.37

2.6

1.7

—

(3017704) Immunofixation for Urine

473

948

2.51

62.89

1.7

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

484

982

2.48

62.80

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

503

1044

2.42

62.30

1.6

4.60

10.08

nmol/l

0.49

420

880

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

160

5.27

62.22

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5098

32484

0.77

62.09

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

675

1600

2.12

61.88

1.6

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

443

869

2.56

61.45

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

188

205

4.60

60.75

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

722

1776

2.05

60.25

1.3

6.40

6.20

mmol/l

0.98

666

1641

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

382

700

2.74

60.17

2.2

2.0

64.32

60.40

ug/l

0.33

374

683

(3045788) Cell count panel - Pleural fluid

689

1667

2.08

60.01

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

119

7.65

59.72

2.2

1.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1857

6063

1.55

59.67

2.0

1.8

191.02

198.50

pmol/l

1.91

1765

5783

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

414

797

2.61

59.55

2.6

2.2

—

(3047189) Immunofixation for 24 hour Urine

405

776

2.62

58.79

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

8706

36306

1.23

58.42

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

146

128

5.72

58.36

2.6

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1590

5038

1.59

58.06

2.9

1.9

0.88

0.81

nmol/l

3.06

1316

4267

(3022493) Free Hemoglobin [Mass/volume] in Plasma

438

882

2.50

57.75

7.1

4.5

1545.79

3910.23

mg/l

1.23

340

605

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

171

179

4.79

57.71

10.2

6.8

0.33

0.35

umol/l

0.36

157

156

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1013

2847

1.79

57.35

1.6

1.5

58.02

54.60

1.68

665

1809

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

409

799

2.57

57.24

2.0

2.8

1.19

1.01

ug/l

0.86

377

752

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

18226

81385

1.16

56.37

4.6

4.5

3.49

2.83

ug/l

1.07

16405

73455

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

532

1189

2.25

56.16

1.1

1558.02

1476.15

miu/ml

0.78

532

1189

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

161

164

4.93

55.88

1.1

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

352

644

2.75

55.65

2.4

1.7

786.19

4925.56

e6/l

1.51

254

422

(3033799) Differential panel - Peritoneal fluid

311

530

2.95

55.54

2.2

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

188

224

4.21

55.09

2.0

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2322

8090

1.45

54.67

1.1

5.45

5.47

u/ml

0.01

275

1167

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

162

170

4.78

54.56

1.1

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

486

1059

2.31

54.33

1.3

1.2

156.72

165.02

mmol/24h

1.09

486

1059

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

357

671

2.67

53.77

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

416

847

2.47

53.69

4.0

3.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

322

575

2.81

53.16

2.8

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

322

575

2.81

53.16

2.8

2.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

517

1171

2.22

52.96

1.2

1.1

9.32

16.68

u/ml

0.57

111

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2845

10343

1.39

52.94

1.3

214.15

227.31

miu/ml

1.03

1180

5091

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

757

1992

1.91

52.52

4.6

3.3

50.26

47.29

u/ml

0.15

750

1965

(3004446) Plasmodium sp identified in Blood by Light microscopy

169

192

4.42

52.30

2.7

2.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3349

22088

0.75

52.24

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

336

621

2.72

52.20

3.8

3.1

52.28

52.20

0.02

331

591

(3036603) Volume of Urine

614

1502

2.06

52.06

1.6

2003.04

1989.79

0.11

598

1457

(3017569) Oxygen content in Arterial blood

405

832

2.45

51.36

2.1

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

564

1349

2.10

50.67

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2519

9035

1.41

50.65

1.9

1.7

39.82

40.74

nmol/l

0.98

2459

8838

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

157

172

4.58

50.57

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

379

763

2.50

50.08

2.4

2.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

776

2093

1.87

50.06

1.6

1.5

30.07

33.16

1.39

492

1302

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

637

1604

2.00

50.05

1.1

1.07

ratio

0.34

216

568

(3004451) EKG impression Narrative

412

868

2.39

49.59

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

363

720

2.53

49.41

1.3

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

312

573

2.73

49.07

2.3

1.6

16357.02

10284.51

e6/l

0.41

181

293

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

395

820

2.42

49.05

1.7

1.9

175.68

154.68

2.72

376

765

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

234

364

3.23

48.32

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

1722

5826

1.49

46.96

5.0

3.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

284

508

2.81

46.83

1.1

1.0

7.32

6.62

mg/g

0.35

266

486

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1457

4765

1.54

46.50

1.5

1.4

0.30

0.45

nmol/l

11.71

1129

3818

(3026692) Albumin [Mass/volume] in Peritoneal fluid

257

436

2.96

46.35

1.6

1.3

13.09

13.39

g/l

0.16

187

333

(3014271) Vancomycin [Susceptibility]

401

862

2.34

46.28

3.1

2.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

567

1423

2.00

45.01

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

757

2105

1.81

44.48

1.4

1.3

1.47

1.41

nmol/l

0.77

687

1895

(3032057) Clostridioides difficile [Presence] in Stool

225

361

3.13

44.38

1.9

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

137

150

4.58

44.23

3.4

2.8

1.25

1.23

mg/l

0.03

109

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

679

1837

1.86

43.48

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

226

370

3.07

43.21

1.5

1.3

23.65

27.29

g/l

2.16

169

296

(3010144) Erythrocytes [#/volume] in Synovial fluid

745

2084

1.80

42.96

1.4

107615.40

94558.97

e6/l

0.21

522

1403

(3029075) Extractable nuclear Ab panel - Serum

326

661

2.48

42.57

1.1

—

(40757373) Influenza virus identified in Isolate

218

354

3.09

42.23

1.7

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

457

1085

2.12

41.94

1.1

91.37

80.72

u/l

1.14

412

980

(3012565) Volume of 24 hour Urine

469

1128

2.09

41.67

2.0

2.2

2014.14

1997.39

0.09

419

1011

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

121

125

4.86

41.54

3.3

2.8

2.26

2.32

mg/l

0.11

104

106

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

455

1085

2.11

41.31

1.1

31.61

20.59

u/l

1.94

410

979

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

668

1830

1.84

41.19

1.3

1.40

2.48

u/ml

2.50

382

1006

(3034274) Bile acid [Moles/volume] in Serum --fasting

1320

4340

1.53

41.17

2.3

2.1

8.79

5.97

umol/l

2.25

971

3152

(3036071) Salmonella sp Ab [Titer] in Serum

355

765

2.33

40.83

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

371

817

2.28

40.68

1.1

107.24

110.22

0.62

340

728

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

275

526

2.62

40.26

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

358

781

2.30

40.09

1.1

90.96

93.86

0.55

179

345

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

7.38

39.78

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.23

39.71

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

521

1331

1.97

39.48

1.3

12.87

14.10

u/l

0.65

475

1249

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

504

1273

1.99

39.41

1.0

750.48

745.01

ng/l

0.09

340

896

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

501

1265

1.99

39.21

1.0

284.18

357.92

ng/l

1.68

353

917

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

361

803

2.26

38.73

1.1

89.44

92.87

0.98

179

348

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

503

1278

1.98

38.71

1.0

38.55

43.00

ng/l

1.12

341

917

(4034850) Laboratory test

2285

8435

1.37

38.71

11.3

8.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1297

4307

1.52

38.68

1.1

160.25

3241.74

iu/ml

0.75

314

980

(3033923) Metanephrine [Moles/time] in 24 hour Urine

217

373

2.92

38.41

1.1

0.68

0.81

umol/24h

0.36

103

196

(3035880) pH of Pleural fluid

416

986

2.12

38.39

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.47

38.25

1.4

1.1

—

(3044007) Cell count panel - Peritoneal fluid

269

523

2.58

38.22

2.3

1.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

193

310

3.12

38.09

1.2

1.3

95.96

159.55

titre

0.33

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

356

793

2.25

38.08

1.4

14.70

14.65

pmol/l

0.03

304

670

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

530

1395

1.91

36.94

1.5

23.03

24.42

u/ml

0.23

103

278

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

250

480

2.61

36.41

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

250

480

2.61

36.41

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

250

480

2.61

36.41

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

250

480

2.61

36.41

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1659

5859

1.43

36.36

2.4

2.3

152.73

94.91

ug/min

3.50

999

3577

(40758292) HTLV I+II Ab panel - Serum

198

336

2.96

35.84

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

229

424

2.71

35.67

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

196

332

2.96

35.59

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

203

352

2.89

35.46

5.0

4.8

67.28

53.38

u/l

0.54

198

346

(3048879) Bone marrow aspiration report

254

501

2.54

35.15

2.3

1.7

—

(3034426) Prothrombin time (PT)

361

840

2.16

34.92

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

458

1176

1.96

34.31

1.1

97.15

96.58

0.13

375

919

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

262

534

2.46

33.99

1.4

1.2

126.75

135.56

nmol/l

0.30

201

403

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

176

3.76

33.94

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

435

1104

1.98

33.67

2.5

2.0

160.57

218.33

ug/l

0.15

418

1044

(3001186) Copper [Moles/volume] in Serum or Plasma

270

562

2.41

33.56

1.5

1.3

16.57

16.85

umol/l

0.38

239

499

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

7929

34382

1.17

33.38

1.5

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

157

243

3.24

32.86

1.4

1.2

52.14

54.31

0.17

124

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

4.68

32.85

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.27

32.59

1.5

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

142

207

3.44

32.42

1.4

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

5.13

32.37

1.1

1.0

3.34

2.40

u/l

0.30

(3006576) Bicarbonate [Moles/volume] in Blood

326

751

2.18

32.35

6.9

5.8

24.83

25.15

mmol/l

0.61

298

686

(3008116) Ketones [Moles/volume] in Urine by Test strip

218

415

2.64

32.33

1.5

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1111

3713

1.51

32.24

4.2

3.2

38.44

33.60

u/ml

0.37

1079

3570

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

214

404

2.66

32.24

1.5

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

348

825

2.12

32.21

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

654

1921

1.71

32.13

2.0

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

195

352

2.78

31.85

2.8

2.5

59.96

35.32

mg/l

0.73

(3024869) Neuronal Ab [Presence] in Serum

184

324

2.85

31.39

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

184

325

2.84

31.22

1.4

1.3

73.02

115.52

ng/l

0.78

122

200

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

568

1616

1.77

31.16

1.4

1.2

4.93

5.38

umol/l

1.95

518

1494

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.07

30.97

5.1

6.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

118

156

3.79

30.72

1.6

1.64

1.49

mg/l

0.13

113

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

893

2876

1.56

30.65

2.2

1.9

24.42

28.31

mg/l

1.14

233

784

(3035320) C reactive protein [Mass/volume] in Body fluid

610

1788

1.71

30.23

2.6

2.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

160

265

3.03

30.22

1.3

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

460

1239

1.87

30.06

1.3

433.75

496.51

titre

0.10

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

286

647

2.22

29.68

1.4

1.3

61.12

63.37

0.43

229

547

(3034891) Synovial lining cells/100 cells in Synovial fluid

414

1086

1.91

29.28

1.6

1.4

5.04

4.01

0.44

247

(3007463) Buprenorphine [Presence] in Urine

4.95

29.22

7.9

7.6

—

(40762365) Oxygen content in Arterial blood by calculation

167

292

2.87

28.88

3.3

3.1

14.86

14.74

ml/dl

0.17

156

271

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

445

1202

1.86

28.86

1.3

63.78

80.10

titre

0.36

102

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

351

874

2.02

28.71

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7325

31923

1.17

28.67

4.4

4.2

31.93

32.04

0.37

5438

22317

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

123

178

3.47

28.44

1.2

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

171

306

2.80

28.43

5.0

4.5

42.18

44.04

ug/min

0.13

128

235

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

326

793

2.06

28.36

1.2

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

4.59

28.34

1.8

1.5

158.41

187.48

ug/g

0.60

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

204

406

2.52

27.88

1.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

1.54

1.91

mg/l

0.35

120

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

2.81

2.39

mg/l

0.30

113

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

1.96

2.29

mg/l

0.18

108

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

1.18

1.05

mg/l

0.09

107

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

2.41

2.61

mg/l

0.11

117

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

1.06

0.72

mg/l

0.63

112

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

2.33

1.76

mg/l

0.46

117

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

1.72

1.76

mg/l

0.03

106

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

112

154

3.65

27.76

1.6

4.21

4.24

mg/l

0.01

107

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

248

544

2.29

27.65

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1617

5984

1.36

27.04

1.8

1.6

—

(3003129) Base excess in Capillary blood by calculation

231

496

2.34

27.01

1.8

1.6

0.45

0.35

mmol/l

0.12

215

471

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

111

156

3.57

26.74

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

237

519

2.29

26.55

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1389

5031

1.39

26.49

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1388

5031

1.39

26.36

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

11.08

26.36

4.4

4.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

131

209

3.14

26.31

1.4

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

238

526

2.27

26.13

1.3

1.2

108.15

107.88

0.03

228

495

(3007916) DNA double strand Ab [Titer] in Serum

146

251

2.92

26.03

1.3

236.75

142.09

titre

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.85

25.91

1.5

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

107

151

3.55

25.66

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

467

1330

1.76

25.65

1.6

1.24

nmol/l

0.03

358

1070

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.00

25.63

3.2

2.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

222

481

2.32

25.49

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

222

481

2.32

25.49

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1235

4414

1.41

25.46

1.6

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

222

482

2.31

25.37

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

756

2452

1.55

25.27

4.5

4.8

104.57

121.57

u/ml

0.23

248

767

(37021550) Renin [Units/volume] in Plasma --upright

205

431

2.39

25.12

1.3

114.23

65.72

mu/l

0.71

156

334

(3052592) Norovirus Ag [Presence] in Stool

184

367

2.52

25.10

1.5

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14166

64968

1.11

25.02

4.0

21.77

21.99

0.81

6262

29783

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.06

24.59

3.2

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

613

1906

1.62

24.47

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

123

200

3.08

24.04

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1306

4764

1.38

23.92

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

106

157

3.39

23.81

1.2

1.1

—

(3018133) Calcium [Moles/volume] in Urine

177

357

2.49

23.65

1.9

2.3

2.65

2.69

mmol/l

0.10

156

324

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

226

511

2.22

23.62

1.2

1.1

84.52

88.86

0.41

140

(3009871) Measles virus Ab [Titer] in Serum

333

875

1.91

23.57

1.7

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

117

187

3.14

23.49

1.5

1.6

109.41

108.60

ug/l

0.02

147

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

225

510

2.21

23.38

1.2

1.1

77.54

76.05

0.11

133

(3051593) INR in Capillary blood by Coagulation assay

340

903

1.89

23.33

8.0

10.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

101

149

3.40

22.83

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

111

3.84

22.61

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

109

3.86

22.52

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

164

327

2.52

22.45

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1190

4323

1.39

22.38

1.1

2.61

3.06

u/ml

0.71

524

2284

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

151

289

2.62

22.36

1.4

1.6

152039.67

324800.70

nmol/l

0.46

123

242

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

168

341

2.47

22.20

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

217

496

2.19

22.15

1.2

367.66

308.75

pmol/l

0.34

155

380

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1630

6229

1.32

22.07

1.5

1.4

129.81

116.52

pmol/l

0.65

1593

6071

(3010370) Gastrin [Moles/volume] in Serum or Plasma

164

330

2.49

22.06

1.8

49.22

42.58

pmol/l

0.29

139

281

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

371

1034

1.80

21.98

2.6

2.8

157.68

131.59

au/ml

0.36

144

(1761868) Lipid panel - Serum or Plasma

21099

112380

0.92

21.86

2.8

2.6

—

(1002224) Polysomnography panel

3068

12673

1.22

21.78

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

116

194

3.00

21.73

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

399

1141

1.76

21.72

3.1

3.3

8.26

8.06

mg/l

0.21

321

912

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

118

200

2.96

21.64

2.2

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

667

2187

1.53

21.34

3.0

2.9

52.69

50.49

mg/l

0.07

490

1550

(3006270) Folate [Moles/volume] in Blood

623

2012

1.56

21.32

1.2

1.1

371.03

375.66

nmol/l

0.20

522

1762

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

822

2819

1.47

21.23

1.1

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

124

3.56

21.23

1.4

1.3

35.05

38.50

0.25

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7647

34110

1.14

21.22

1.7

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

152

3.27

21.17

1.2

—

(3024263) Appearance of Synovial fluid

409

1188

1.73

21.13

1.5

1.4

—

(3013862) HLA-DP [Type]

5.19

21.13

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

179

386

2.33

20.88

2.5

2.0

1.18

1.19

mmol/l

0.77

171

368

(44813793) Dust mix specific IgE antibody measurement

623

2022

1.55

20.88

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.99

20.63

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

140

269

2.61

20.63

2.8

2.1

0.88

1.62

mmol/l

3.27

199

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.06

20.52

12.0

9.8

284.19

178.45

e6/l

0.36

(3032743) Legionella sp IgG Ab [Presence] in Serum

120

3.55

20.47

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

110

185

2.98

20.45

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

169

359

2.36

20.38

2.4

1.9

1.19

1.20

mmol/l

0.28

164

340

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

213

501

2.13

20.35

1.3

425.92

178.54

ug/l

0.75

110

279

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

127

3.43

20.02

1.3

1.1

24.05

17.77

0.37

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

428

1285

1.67

19.68

1.2

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

229

565

2.03

19.41

1.4

1.3

3.25

2.67

0.36

187

485

(3035933) Granulocytes/100 leukocytes in Blood

279

740

1.89

19.33

2.5

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

361

1040

1.74

19.24

1.4

461.10

725.85

mu/l

1.48

341

992

(3021162) Amylase [Enzymatic activity/volume] in Specimen

151

313

2.42

19.20

2.6

2.9

1379.28

1981.74

u/l

0.37

137

284

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

104

176

2.96

19.18

1.1

21.94

20.52

u/l

0.21

109

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

367

1064

1.73

19.15

1.4

73.56

72.51

0.76

347

1016

(40760410) HLA-B [Type] by High resolution

4.92

19.02

1.0

—

(40763590) HLA-DQ beta [Type]

4.92

19.02

1.0

—

(40760409) HLA-A [Type] by High resolution

4.92

19.02

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

155

327

2.38

19.00

1.1

4.56

9.34

pmol/l

0.36

(3042951) Complement C1q Ab [Units/volume] in Serum

4.08

19.00

1.1

1.2

30.21

16.19

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

105

3.63

18.88

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

122

229

2.67

18.82

1.1

—

(46236302) HLA-C [Type] by High resolution typing

4.83

18.69

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

241

615

1.97

18.67

1.9

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

129

3.30

18.55

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.96

18.48

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

241

619

1.95

18.35

1.3

1.2

39.15

40.29

g/l

0.46

131

325

(43055514) Macroprolactin [Presence] in Serum or Plasma

288

786

1.84

18.34

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

10916

50098

1.11

18.32

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

5.11

18.30

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

121

230

2.64

18.26

5.5

5.1

68.14

84.76

g/mol

0.16

110

211

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

140

287

2.45

18.24

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

123

3.34

18.21

1.3

1.4

78.73

82.86

umol/l

0.39

110

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

147

3.10

18.10

2.5

2.1

62.64

57.56

0.50

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

154

333

2.32

17.94

1.1

1.0

0.11

0.38

u/ml

1.02

206

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

221

555

2.00

17.92

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

102

3.59

17.89

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

171

392

2.19

17.47

4.8

7.0

66.53

71.98

1.50

127

319

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

544

1787

1.53

17.38

1.1

8.59

8.03

iu/ml

0.18

122

494

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

151

3.02

17.37

1.3

1.4

17.05

12.00

pmol/l

0.40

130

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.62

17.35

1.1

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

103

185

2.79

17.24

2.3

2.0

1.26

1.33

umol/l

1.03

162

(3002619) Bacteria identified in Specimen by Culture

187

449

2.09

17.07

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

183

436

2.11

17.04

1.4

23.98

22.11

0.34

146

378

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

126

255

2.48

16.89

2.1

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

374

1131

1.66

16.84

1.2

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

1739

6958

1.26

16.60

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.35

16.47

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

173

409

2.12

16.44

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

119

3.24

16.42

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

132

278

2.38

16.33

1.7

1.6

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

125

3.17

16.26

1.3

1.4

18.60

16.39

pmol/l

0.28

108

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

130

273

2.39

16.18

3.4

2.6

20.84

23.32

mg/l

1.25

121

261

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

426

1346

1.59

16.16

1.8

1.7

2.40

2.45

u/field

0.04

307

974

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

134

3.07

16.07

1.2

1.5

—

(3017509) Phencyclidine [Presence] in Urine

152

345

2.21

15.94

2.0

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

217

566

1.92

15.90

1.3

3.54

3.65

mmol/l

0.14

193

519

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

4.01

15.84

1.1

0.04

0.66

mg/l

0.51

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

212

551

1.93

15.70

9.4

7.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

191

479

2.00

15.62

1.6

1.5

0.40

0.41

ug/l

0.15

142

305

(3051339) Copper [Moles/volume] in Blood

100

3.41

15.59

1.2

1.4

15.98

16.90

umol/l

0.90

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

103

196

2.63

15.59

1.1

1.69

1.75

umol/24h

0.18

103

196

(3011544) Albumin [Mass/volume] in Pleural fluid

156

2.86

15.58

1.2

1.1

15.98

18.70

g/l

1.99

142

(3000919) Neutrophils/100 leukocytes in Pleural fluid

200

511

1.96

15.55

1.4

1.3

25.60

20.21

1.61

177

472

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

127

269

2.37

15.55

3.4

2.7

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

5.13

15.48

6.3

6.1

1.59

1.40

mg/l

0.14

(3013166) Neutrophils/100 leukocytes in Synovial fluid

239

651

1.84

15.41

1.4

57.01

52.42

1.03

201

555

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

123

259

2.38

15.26

7.7

7.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

333

1004

1.66

15.22

2.1

1.9

8.70

9.56

mg/l

2.01

269

799

(3016330) Potassium [Moles/time] in 24 hour Urine

149

343

2.18

15.15

1.3

96.98

71.27

mmol/24h

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.28

15.13

1.7

1.5

227.39

317.50

nmol/l

0.36

(3019174) dRVVT (LA screen)

108

215

2.52

15.02

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1633

6566

1.25

14.99

1.1

1.89

2.34

u/ml

1.00

864

3319

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

149

2.86

14.90

2.3

3.3

85.19

448.39

pmol/l

0.42

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

5.62

14.82

5.1

5.5

4.98

8.26

mg/l

0.55

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

115

3.14

14.66

1.5

1.4

15.72

10.73

0.75

(3044009) aPTT.lupus sensitive (LA screen)

108

218

2.48

14.63

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.28

14.38

1.0

1.1

0.20

0.22

g/l

0.84

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

190

491

1.94

14.36

2.2

2.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

133

2.94

14.33

2.9

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

527

1799

1.47

14.15

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.83

14.08

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

295

880

1.68

14.08

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

468

1562

1.50

14.02

1.4

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

123

270

2.28

13.99

1.4

1.3

10.73

12.44

0.29

139

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

408

1324

1.55

13.90

6.5

6.0

433.31

3991.01

u/ml

0.85

272

(3011335) Digoxin [Mass/volume] in Serum or Plasma

125

2.97

13.83

2.2

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

151

2.76

13.69

1.7

50.87

41.25

umol/l

1.72

151

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.01

13.36

1.7

1.5

300.70

197.18

nmol/l

0.46

(3026726) Creatinine [Moles/volume] in Specimen

162

2.66

13.34

2.7

2.2

502.54

357.41

umol/l

0.31

157

(3009677) Dengue virus Ab [Presence] in Serum

3.53

13.32

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

186

491

1.90

13.27

8.9

7.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

118

2.97

13.14

2.6

2.2

14.45

17.58

0.31

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.73

13.06

1.2

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

185

2.52

13.02

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

126

289

2.19

13.00

2.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

141

339

2.09

12.97

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1469

5938

1.24

12.93

1.1

5.07

5.87

u/ml

1.04

797

3111

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.72

12.71

1.2

1.5

458.74

554.16

nmol/l

0.44

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

354

2.04

12.54

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

159

406

1.96

12.50

2.0

2.6

7.40

7.49

mmol/l

0.09

113

214

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

307

957

1.61

12.45

1.1

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.84

12.43

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

138

335

2.07

12.42

1.1

—

(3024316) Viscosity of Plasma

3.23

12.40

1.5

1.8

1.50

1.82

mpas

1.67

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.58

12.34

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

532

1870

1.43

12.34

2.1

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

138

336

2.06

12.33

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.25

12.28

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

564

2007

1.41

12.23

1.9

1.7

6.81

6.54

mmol/l

1.14

437

1478

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

153

2.62

12.11

1.0

13.82

21.01

u/ml

0.77

126

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2398

10236

1.18

12.06

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1395

5653

1.24

12.04

1.1

1.01

1.19

u/ml

0.39

627

2440

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

128

2.78

11.96

6.6

4.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

549

1954

1.41

11.91

2.1

1.9

1.74

2.39

u/field

1.77

256

864

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

112

2.91

11.82

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1046

4107

1.28

11.82

1.3

—

(3014891) Appearance of Pleural fluid

105

234

2.25

11.64

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

203

2.35

11.55

1.3

1.2

6.03

6.30

mmol/l

0.14

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1399

8551

0.82

11.52

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

143

363

1.98

11.47

2.2

2.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

170

2.48

11.43

1.3

1.19

1.77

ml/s/173m2

0.55

101

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

455

1578

1.45

11.39

6.6

6.7

—

(3005033) Fetal Nuchal fold Thickness US

1398

8534

0.82

11.37

1.5

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.20

11.36

5.7

3.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

101

2.98

11.35

1.4

1.2

1.21

0.84

0.38

(40758047) Lysozyme [Mass/volume] in Pleural fluid

162

2.51

11.29

1.1

9.81

9.48

mg/l

0.08

149

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

263

810

1.63

11.25

1.8

1.7

159.19

120.37

au/ml

0.40

107

(3016750) Collection duration of Urine

414

1415

1.47

11.18

2.5

2.1

505.97

496.71

min

1.10

306

1092

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1438

8736

0.82

11.15

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.15

11.15

1.0

0.26

0.10

u/ml

0.54

(3004775) Volume in Urine collected for unspecified duration

534

1915

1.40

11.14

2.5

2.3

733.45

657.27

3.34

371

1348

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

221

2.25

10.96

1.2

1.3

79.38

221.71

u/l

0.50

162

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

227

678

1.68

10.92

1.5

1.6

9.19

8.83

ug/l

0.52

227

678

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.52

10.92

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

389

1321

1.48

10.86

1.1

8.12

10.20

u/ml

0.43

230

(40768793) Breast Pathology biopsy report

1407

5775

1.22

10.83

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

197

568

1.74

10.75

1.3

1.2

—

(4212803) Bone marrow aspirate examination

158

2.47

10.63

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.89

10.47

1.2

1.0

—

mmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

157

2.46

10.37

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

107

2.81

10.35

1.3

1.1

1.14

1.13

u/field

0.02

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

132

339

1.95

10.31

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

278

889

1.57

10.26

1.1

2.59

10.97

u/ml

1.17

145

525

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.81

10.22

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.81

10.22

1.1

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

337

1126

1.50

10.22

2.1

165.51

81.11

ug/min

0.66

251

(3005011) Chlamydia sp Ab [Titer] in Serum

137

359

1.91

10.12

1.5

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1362

5617

1.22

10.04

1.1

1.54

2.21

u/ml

2.18

733

2807

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

118

294

2.01

10.03

1.0

0.18

0.21

u/ml

0.14

178

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

101

237

2.14

9.99

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

170

481

1.77

9.93

1.4

5.57

5.84

nmol/l

0.37

161

459

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.06

9.87

1.6

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

747

2877

1.30

9.87

1.3

1.4

8.60

8.00

mmol/l

3.00

722

2779

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

219

2.17

9.82

1.3

1.2

51.57

44.83

mg/l

0.67

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

162

454

1.79

9.77

1.6

1.4

0.21

0.25

nmol/l

0.60

117

327

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

111

2.71

9.74

1.1

63.75

56.81

u/l

0.12

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

532

1955

1.37

9.67

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

202

607

1.67

9.58

1.4

1.3

38.27

40.09

0.25

140

403

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

212

1678

0.63

9.57

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

186

2.26

9.54

1.1

1.0

8.70

2.64

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

167

2.34

9.53

1.1

30.30

32.92

u/ml

0.08

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

167

2.34

9.53

1.1

22.25

28.39

u/ml

0.39

(44786800) Granulocytes/100 leukocytes in Body fluid

232

2.12

9.52

1.3

22.95

25.52

0.29

179

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

198

593

1.67

9.51

3.2

2.4

126.67

98.44

ng/l

0.70

126

301

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.64

9.40

1.0

—

(4281824) Cell count and differential, peritoneal fluid

699

2689

1.30

9.35

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2720

11963

1.14

9.30

2.0

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1402

5850

1.20

9.22

4.1

2.9

26.61

26.70

mg/l

0.03

865

3666

(3015350) Toxocara sp Ab [Presence] in Serum

6.19

9.18

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

2.81

8.85

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

236

2.06

8.83

1.5

1.7

180.00

171.25

mmol/l

0.24

217

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

103

2.68

8.77

1.1

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

152

2.34

8.72

1.1

7.74

14.37

iu/ml

0.80

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

329

1134

1.46

8.65

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

132

2.43

8.50

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

116

307

1.89

8.42

2.6

2.7

71.97

73.78

pmol/l

0.04

271

(3033942) Copper [Moles/time] in 24 hour Urine

101

2.63

8.22

1.4

1.2

1.32

0.76

umol/24h

0.41

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

209

2.09

8.21

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.85

8.19

1.2

0.06

0.08

g/l

0.77

(3041918) Cholesterol [Moles/volume] in Pleural fluid

130

361

1.81

8.16

1.2

1.48

1.79

mmol/l

1.81

212

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

334

1169

1.43

8.14

1.8

1.9

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

450

1662

1.36

8.03

1.4

5.62

5.56

mmol/l

0.47

418

1576

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

4.10

7.99

1.3

1.4

102.05

34.58

e6/l

0.89

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

113

303

1.87

7.92

1.8

1.7

1.60

1.71

mg/l

0.38

252

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

162

485

1.67

7.89

1.3

1.2

76.20

39.25

mg/l

0.35

114

350

(3027974) Hepatitis B virus e Ag [Presence] in Serum

150

2.27

7.87

1.4

1.6

—

(3013466) aPTT in Blood by Coagulation assay

150

2.27

7.87

1.1

35.66

36.92

0.72

124

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1810

10453

0.86

7.82

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1807

10433

0.86

7.78

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1812

10458

0.86

7.77

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1802

10403

0.86

7.75

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

142

2.29

7.69

1.2

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.25

7.68

1.0

1.1

5.84

4.71

mmol/l

0.74

(37019676) Renin [Units/volume] in Plasma --supine

3.73

7.66

1.2

1.1

57.24

65.00

mu/l

0.07

(3042010) Triglyceride [Moles/volume] in Pleural fluid

103

272

1.90

7.57

1.3

1.2

1.02

1.43

mmol/l

0.35

170

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

106

2.51

7.53

3.7

3.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.76

7.45

1.0

0.14

0.08

u/ml

0.30

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.96

7.45

1.1

1.0

235.91

241.51

pmol/l

0.02

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

110

300

1.84

7.36

1.0

1.1

0.80

3.42

u/ml

2.13

233

(3021374) Sirolimus [Mass/volume] in Blood

6.08

7.34

10.7

5.9

7.04

6.55

ug/l

—

(3022229) Phosphate [Moles/volume] in Urine

123

2.36

7.33

1.5

2.4

21.31

19.96

mmol/l

0.15

110

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.78

7.33

1.1

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

108

2.46

7.28

1.6

1.7

197.35

192.03

ng/l

0.17

(3001556) Androgen free Index in Serum or Plasma

121

342

1.77

7.24

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

156

2.18

7.23

1.1

8.35

10.30

u/l

0.43

156

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

115

2.40

7.17

1.3

2433.36

611.04

u/l

0.59

102

(3013945) Hepatitis B virus e Ab [Presence] in Serum

147

2.22

7.15

1.4

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.08

7.11

2.9

3.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

125

2.33

7.10

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

261

1.88

7.06

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1949

11108

0.88

7.00

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

118

335

1.77

6.97

1.2

1.3

35.64

42.33

mg/l

0.89

288

(3021691) Plasmodium malariae Ab [Titer] in Serum

5.01

6.94

2.5

2.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

5.30

6.93

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.48

6.86

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

171

2.08

6.74

1.0

2.32

1.67

u/ml

0.13

135

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.14

6.73

9.1

6.8

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

4.38

6.72

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

4.38

6.72

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

4.38

6.72

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

4.38

6.72

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

4.38

6.72

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

4.38

6.72

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.17

6.61

1.0

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

127

2.25

6.52

1.1

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

4.08

6.51

1.1

26.07

28.89

umol/24h

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

109

309

1.77

6.51

1.0

1.1

2.83

5.56

u/ml

0.52

239

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

149

2.12

6.29

1.3

1.2

108.34

112.42

ug/l

0.08

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

306

1.75

6.22

1.3

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.68

6.20

1.1

1.79

0.93

u/field

0.57

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

107

307

1.75

6.16

1.0

0.16

1.97

u/ml

0.84

164

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

334

1.71

6.11

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

126

381

1.66

6.03

7.2

6.6

—

(3006462) Nitrate [Presence] in Urine

343

1276

1.35

5.99

3.0

2.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

135

417

1.62

5.97

1.2

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

177

1.98

5.91

1.1

2.90

1.98

u/ml

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.90

5.91

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

4.73

5.90

1.0

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.35

5.84

13.4

9.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.80

5.83

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.37

5.83

1.6

1.5

0.00

0.11

u/l

0.73

(3007919) Fasciola sp Ab [Titer] in Serum

3.44

5.76

1.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

9.30

5.74

1.9

1.0

18.00

31.00

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9933

47377

1.06

5.69

2.8

0.73

0.76

ug/l

1.46

6513

29465

(3015183) Erythrocyte sedimentation rate

408

1570

1.30

5.67

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

10.02

5.51

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.34

5.30

1.1

344.14

402.87

u/l

0.13

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

143

465

1.54

5.17

1.8

2.40

2.83

ug/l

0.25

286

(3027035) Albumin [Mass/time] in 24 hour Urine

208

1.83

5.17

1.4

1.2

378.14

266.42

mg/24h

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.86

5.16

8.1

7.1

43.30

39.33

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1018

4363

1.17

5.15

1.4

1.3

7.12

7.01

mmol/l

0.55

914

3874

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1115

4814

1.16

5.14

1.1

4.66

4.29

u/ml

0.19

540

2339

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.47

4.96

1.0

0.07

0.36

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

165

559

1.48

4.96

1.1

1.2

8.07

7.53

u/ml

0.04

111

405

(3027231) Wheat IgE Ab [Units/volume] in Serum

182

631

1.45

4.88

1.0

1.1

5.78

2.58

u/ml

0.37

150

545

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.01

4.79

1.0

0.03

0.13

u/ml

0.51

(3018834) Bilirubin.total [Presence] in Urine by Test strip

108

2.13

4.77

3.7

3.4

0.00

estimate

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

909

3888

1.17

4.76

1.1

1.0

0.47

0.43

u/ml

0.08

289

992

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

233

1.74

4.73

1.4

71.18

71.78

0.05

202

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

101

309

1.64

4.73

1.0

0.09

0.41

u/ml

1.11

168

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1043

4512

1.16

4.73

1.1

5.84

5.35

u/ml

0.23

440

1930

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

10.02

4.67

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2552

11666

1.10

4.66

1.9

1.5

4.39

3.62

mg/l

2.76

1994

8112

(3039443) Prostate specific Ag panel - Serum or Plasma

958

5561

0.86

4.64

1.6

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

7.87

4.57

1.2

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

185

1.81

4.49

1.3

1.1

15.72

15.62

nmol/l

0.01

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

258

965

1.34

4.48

1.1

1.0

11.14

11.98

u/ml

0.19

137

567

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

129

1.98

4.41

2.1

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.18

4.38

11.2

8.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

126

1.99

4.37

1.4

1.8

0.68

0.64

umol/l

0.18

103

(3049233) Organic acids panel - Urine

3.28

4.34

1.1

1.2

—

(36303858) Crystals [Presence] in Urine

3.28

4.34

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.39

4.30

2.3

2.5

—

(3022475) Manganese [Moles/volume] in Blood

148

1.90

4.29

1.1

1.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.13

4.27

1.4

1.0

—

(3018291) Platelet Ab [Presence] in Serum

3.13

4.27

1.1

—

(3022689) Creatine [Moles/volume] in Urine

200

725

1.38

4.25

1.6

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2263

10337

1.10

4.24

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

490

2004

1.23

4.23

1.1

2.65

4.09

u/ml

0.38

132

520

(3017400) Magnesium [Moles/volume] in Urine

2.81

4.16

1.3

1.0

2.08

3.07

mmol/l

1.08

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.51

4.13

1.0

0.62

0.99

u/ml

0.31

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

213

1.72

4.12

1.1

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

3.76

4.08

1.3

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

3.76

4.08

1.3

1.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

155

1.84

4.04

1.0

0.30

0.76

u/ml

0.94

145

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3660

19636

0.93

4.03

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

497

2054

1.21

3.91

1.1

1.03

3.25

u/ml

1.68

177

674

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

283

1.59

3.87

1.0

1.1

0.56

0.45

u/ml

0.12

161

(3010937) Rubella virus Ab [Presence] in Serum

176

1.77

3.86

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

139

482

1.45

3.82

1.3

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

207

1.69

3.80

1.1

1.0

0.78

0.96

u/ml

0.22

130

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.34

3.77

1.0

1.2

273.62

414.10

pmol/l

0.60

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

116

1.94

3.75

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

103

338

1.53

3.71

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

252

969

1.30

3.70

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

226

1.64

3.59

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

363

1467

1.24

3.57

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.62

3.57

3.0

1.8

3.07

1.81

mu/l

0.50

(3035082) Kappa light chains [Mass/volume] in Urine

2.62

3.57

1.0

1.1

0.02

0.05

g/l

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

4.62

3.56

1.0

1.6

326.17

289.15

nmol/l

0.32

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.21

3.46

1.2

3429.39

3025.43

ng/l

0.11

(3001729) Color of Synovial fluid

175

1.72

3.45

1.5

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

128

1.84

3.38

1.2

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

342

1385

1.24

3.34

2.0

4.34

3.53

ug/l

0.55

308

1279

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1115

4975

1.12

3.33

1.4

1.3

3.81

3.72

ug/l

0.09

993

4519

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

2.82

3.31

1.1

1.3

697.00

76.33

au/ml

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.34

3.31

1.1

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.29

3.24

1.0

0.07

0.28

u/ml

0.51

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

218

1.61

3.19

1.0

2.42

0.74

u/ml

0.51

151

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

195

1.64

3.18

1.0

1.1

4.23

8.93

u/ml

2.09

133

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.68

3.17

1.0

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

117

409

1.43

3.16

1.0

79.65

81.06

ug/l

0.13

337

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.73

3.15

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

200

1.63

3.12

1.1

1.0

0.36

0.86

u/ml

0.46

118

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

208

1.61

3.11

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

331

1349

1.23

3.08

2.1

2.60

2.30

ug/l

0.45

275

1143

(4146454) Self-monitoring of blood glucose

609

2624

1.16

3.08

2.8

—

(3027874) Urate [Moles/volume] in Urine

2.09

3.06

1.1

1.77

10.86

mmol/l

0.50

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.40

3.04

1.5

1.4

135.00

129.07

nmol/l

0.05

(3015076) Soybean IgE Ab [Units/volume] in Serum

433

1815

1.20

3.04

1.0

1.21

0.61

u/ml

0.44

120

453

(3035611) Eosinophils/100 leukocytes in Synovial fluid

148

1.73

3.03

1.5

1.8

1.20

0.49

0.87

115

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.45

3.02

1.2

1.0

3.67

2.16

1.00

(3028468) Fragments [Presence] in Blood by Light microscopy

4.55

3.02

2.5

2.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.95

2.83

2.0

2.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.06

2.80

1.1

—

(3041184) Isoniazid [Presence] in Urine

3.10

2.79

3.3

2.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

3.67

2.75

4.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

876

4919

0.89

2.74

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.00

2.62

1.0

0.15

0.05

u/ml

0.53

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

486

2827

0.86

2.62

1.6

1.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.38

2.62

1.4

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

167

1.62

2.60

2.7

4.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

177

1.59

2.49

1.4

330.07

313.69

umol/24h

0.23

177

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

3.58

2.48

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

4.45

2.46

1.1

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

4.45

2.46

1.1

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.24

2.44

1.9

1.2

—

(40762814) Titanium [Mass/volume] in Blood

104

378

1.38

2.36

2.2

2.4

4.25

3.75

ug/l

0.27

120

(3020650) Glucose [Presence] in Urine

194

771

1.26

2.36

1.5

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

156

1.61

2.36

1.1

1.0

0.48

13.02

u/ml

0.50

(3019529) Immunofixation for Cerebral spinal fluid

6.01

2.34

1.7

1.0

—

(3045177) Copper [Moles/volume] in Urine

2.43

2.32

1.2

1.0

0.74

0.30

umol/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

185

1.54

2.29

4.8

2.4

15.01

13.24

0.17

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.71

2.29

1.5

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.91

2.24

1.1

245.31

256.80

nmol/l

0.11

(1617658) Protocol used for examination of sentinel lymph nodes

435

1889

1.15

2.12

1.1

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.97

2.02

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

138

539

1.28

1.99

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

140

1.57

1.97

1.0

0.48

10.47

u/ml

0.50

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.80

1.95

1.1

1.2

—

(3013762) Body weight Measured

102

1.67

1.91

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.95

1.89

1.0

2.63

0.65

u/ml

0.36

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.41

1.88

1.1

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

167

1.50

1.83

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

3.08

1.81

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

3.08

1.81

1.0

1.1

9.25

20.46

umol/l

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.08

1.81

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

652

2940

1.11

1.81

1.6

7.92

7.61

mmol/l

2.84

629

2815

(3006969) Lambda light chains [Mass/volume] in Urine

2.03

1.71

1.0

1.1

0.02

g/l

—

(3002853) Influenza virus B Ab [Titer] in Serum

2.86

1.68

1.0

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

2.09

1.62

1.4

0.67

0.56

u/field

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.09

1.62

1.0

1.1

0.11

0.32

u/ml

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.92

1.58

2.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

362

1.30

1.57

9.6

5.4

—

(3043614) Bacteria identified in Aspirate by Culture

3.34

1.57

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

213

1.39

1.51

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

266

1.34

1.46

1.6

1.5

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

131

1.49

1.45

1.3

1.65

1.70

mg/l

0.09

107

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

3.58

1.44

2.0

2.9

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.70

1.43

1.0

1.1

20.43

36.23

umol/l

—

(3025130) Human papilloma virus identified in Specimen

954

4435

1.08

1.43

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

240

1036

1.16

1.39

3.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

281

1609

0.87

1.39

1.6

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2494

13054

0.96

1.38

1.5

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

366

1.27

1.36

3.7

1.3

7.39

7.11

mmol/l

0.26

115

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.76

1.34

1.5

1.6

100.55

123.31

ug/l

0.27

(3045759) Histamine [Moles/volume] in Serum or Plasma

2.50

1.32

1.9

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

2.73

1.30

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.53

1.29

1.4

1.3

1.00

1.14

u/field

0.58

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

325

1.28

2.6

2.2

0.55

0.61

u/field

0.20

325

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

119

1.47

1.26

1.0

1.1

—

(3032641) Amino acids panel - Urine

2.12

1.26

1.1

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

134

804

0.83

1.24

1.3

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.77

1.23

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.90

1.23

1.7

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.18

1.21

1.2

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.67

1.20

1.0

—

0.98

—

(40758358) Immune stain study

1.51

1.19

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

451

0.79

1.15

5.7

5.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.67

1.15

2.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.74

1.11

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.74

1.11

1.2

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.75

1.00

1.5

1.2

67.07

77.63

0.20

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.50

0.99

1.0

1.2

29.65

34.23

nmol/24h

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3446

17783

0.97

0.99

1.7

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

264

1181

1.12

0.99

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.61

0.98

1.6

1.4

2.13

2.16

mmol/24h

0.04

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

385

1.21

0.95

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.15

0.89

1.2

1.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.56

0.88

2.0

2.6

35.41

26.54

nmol/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.55

0.87

5.5

5.4

0.12

0.25

mmol/l

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

109

1.38

0.83

1.0

0.13

0.24

u/ml

0.46

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

105

1.38

0.82

1.0

0.10

0.28

u/ml

0.75

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

319

1.21

0.82

1.3

1.2

20.99

20.43

mmol/l

0.54

264

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.44

0.81

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

176

1.28

0.79

1.1

0.59

2.26

u/ml

1.58

119

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

208

1.25

0.77

1.3

7.18

6.08

u/ml

0.07

173

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

136

0.70

0.76

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.67

0.70

1.0

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.38

0.70

1.0

0.10

0.21

u/ml

0.42

(3003577) Lead [Moles/volume] in Blood

234

1.22

0.69

1.2

1.5

0.20

0.23

umol/l

0.15

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

151

673

1.12

0.68

1.8

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1728

8941

0.97

0.66

1.8

1.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.58

0.64

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.67

0.64

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.54

0.59

1.0

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

1.67

0.57

1.2

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.35

0.54

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.46

0.47

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

186

1.19

0.45

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

1.67

0.44

1.6

1.1

—

(3009883) Potato IgE Ab [Units/volume] in Serum

1.45

0.43

1.0

0.34

0.50

u/ml

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.43

0.0

1.0

—

(3008607) Semen analysis panel

276

1.14

0.43

1.3

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.39

0.42

1.0

412.83

360.97

umol/l

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.67

0.41

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

198

928

1.07

0.38

3.0

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

197

928

1.06

0.34

6.1

6.4

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.27

0.34

1.0

9.77

10.59

u/ml

0.05

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

511

2651

0.97

0.32

1.4

1.3

179.70

189.09

pmol/l

0.18

511

2651

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.25

0.31

1.4

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.35

0.29

1.0

1.1

1508.00

2122.16

titre

—

(3003157) Bacteria [#/volume] in Mother's milk

1.23

0.26

4.7

7.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.82

0.25

1.0

165.14

163.60

g/l

0.10

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.39

0.24

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1465

7447

0.99

0.21

1.5

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

101

1.14

0.19

1.0

0.24

0.89

u/ml

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.72

0.17

1.2

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

397

1.06

0.17

1.3

1.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.77

0.16

1.2

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

398

2037

0.98

0.15

1.4

29.76

32.12

nmol/l

0.90

354

1886

(3034614) HLA Ag [Interpretation]

1.13

0.11

1.5

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.19

0.10

1.0

—

(3006598) pH of Arterial cord blood

222

0.95

0.09

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

234

1.05

0.08

1.0

9.53

8.40

mu/l

0.51

188

(3022670) pH of Venous cord blood

0.91

0.08

1.1

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

221

0.95

0.08

1.0

7.02

7.28

kpa

0.45

193

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

185

0.95

0.08

1.1

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

1.09

0.06

1.1

1.4

—

(3004959) Base excess in Arterial cord blood by calculation

218

0.97

0.05

1.0

-1.42

-2.10

mmol/l

0.24

(40768800) Prostate Pathology biopsy report

956

4812

1.00

0.04

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1934

9696

1.00

0.01

1.5

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

214

0.98

0.01

1.0

4.40

3.72

kpa

0.34

184

(3019897) Erythrocyte distribution width [Ratio] by Automated count

938

4701

1.00

0.00

3.1

2.3

13.12

0.04

927

4639

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_GENERAL_SYMPTOMS_SIGNS – General symptoms and signs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

General symptoms and signs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for General symptoms and signs (R18_GENERAL_SYMPTOMS_SIGNS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints